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ABSTRACT
GENETIC CONTROL OF IMMUNE RESPONSIVENESS TO THE 
AVIAN COCCIDIUM EIMERIA TENELLA
by
ROBERT A. CLARE 
University of New Hampshire, May, 1988
Specific inbred lines of chickens expressing different 
major histocompatibility (B) complex haplotypes were studied 
for their immunogenetic response to the a* ian coccidium 
Eimeria tenella and genetically-engineered antigens cloned 
from this parasite species. The relative influence of the 
B-F vs. B-G chromosomal regions on innate resistance and 
immunity to E. tenella was studied among six B-F/B-G 
recombinant hosts. F^ chicks of similar genotypes, BR3 and 
gR4 (gF2-G23gl7j ^ gained significantly more weight than 
those with BR1 (BF24-g23b17) and BR5 (bF21-g 19b 17) following 
exposure to a single high dose of 25,000 oocysts, although 
no differences in cecal lesion scores were detected. 
Following exposure to a single low dose of 2500 oocysts, F
T3 A
chicks B*w  and B again gained significantly more weight
and had significantly lower lesion scores compared to BR1 or 
R5 •B F1 chicks. Acquired immunity in F2 homozygous 
recombinant chicks was studied using five consecutive daily 
exposures of 500 oocysts followed 21 days later by challenge 
with 10,000 oocysts. BR5 (BF21-G19) and BR6 (bF21-G23j
homozygous chicks, both carrying the B-F21 allele, showed 
significant protection in terms of reduced lesion scores.
The immunogenicity of recombinant E. tenella coccidial 
antigens 5401 and 3264 was studied in 6-^ .B congenic chickens 
derived from JJ2B2 and B5B5 parents segregating for 
haplotypes B2 and B5. In separate experiments, antigens 5401 
and 3264, both inoculated subcutaneously in Freund's 
complete adjuvant, elicited a protective response only in 
B5B5 chickens. B2B2 and B5B^ chickens also responded 
differently in serum IgG titer and in the magnitude of 
lymphocyte proliferation. Western blot analysis showed 
differential labeling of low molecular weight proteins. 
Antibodies raised against antigen 3264 strongly labeled only 
the anterior portion of the sporozoite stage of E. tenella. 
In contrast, these same antibodies strongly labeled only the 
posterior portion of second generation merozoites, while 
first generation merozoites were only slightly labeled, if 
at all. In addition, a single heavily labeled nodule, 
possibly an immune complex, was observed on the posterior 
surface of second generation merozoites.
Considered together, these findings demonstrate further 
that genetic responsiveness is linked to the major 
histocompatibility complex and has a profound influence on 
the host response to the parasite as well as the efficacy of 
recombinant protozoan vaccines.
INTRODUCTION
The avian coccidia are obligate intracellular protozoan 
parasites of intestinal epithelium. They belong to the 
Phylum Apicomplexa, including such genera as Plasmodium. 
Sarcocvstis. Toxoplasma. and Cryptosporidium. all of which 
exhibit similar life cycles. Immunity to any one of these 
parasites appears to be directed at the sporozoite, the 
first parasitic stage to invade a host cell. Complete 
neutralization of the sporozoite would prevent the 
debilitating effects of these parasites. Because of the 
tremendous reproductive capacity of these organisms, even a 
few sporozoites evading the host response could still 
produce a fulminating infection.
Since sporozoite surface antigens are likely candidates 
to trigger the host immune response, it appears reasonable 
that these antigens could be used in the manufacture of a 
vaccine. Sporozoite antigens have been successfully cloned 
from Plasmodium and Eimeria species. The efficacy of these 
candidate vaccines depends upon priming the host's immune 
system such that an anamnestic response would be triggered 
by a natural infection with the parasite. As with other 
vaccines, responder and non-responder hosts exist. 
Therefore, a complete understanding of the molecular 
interactions between the host and a given vaccine antigen is
1
2necessary. For the host, a primary interaction is at the 
level of the major histocompatibility complex (MHC).
The chicken MHC, or B complex, is not well understood, 
and only recently has the molecular organization of this 
tightly-linked genetic region been investigated. The 
association of the B complex with several viral diseases in 
chickens is well established, as is its influence on 
immunity to avian coccidiosis. Since the coccidia are now 
the subject of intense vaccine research, it is appropriate 
to investigate the role the MHC may have on the efficacy of 
a candidate coccidial vaccine. Therefore, the purpose of 
this dissertation is to:
1. Investigate further the effect of the MHC on the fate of 
Eimeria tenella parasitism by examining both a primary 
and subsequent secondary infection in six MHC B-F/B-G 
recombinant chicken hosts.
2. Investigate the immunogenic efficacy of two genetically- 
engineered coccidial proteins in chicken hosts congenic 
for the B locus.
3. Investigate the antigenic nature of sporozoites and 
merozoites of E. tenella using antibodies raised against 
a recombinant coccidial antigen.
3REVIEW OF THE LITERATURE 
The Avian Maior Histocompatibility Complex
The B complex, discovered by Briles and coworkers 
(1950) , was originally identified as an avian blood group 
system of erythrocyte antigens. This highly polymorphic 
locus was later shown to be the marker for the chicken major 
histocompatibility complex (Schierman and Nordskog, 1961). 
At present, 27 B haplotypes have been identified in 32 
different populations tested from laboratories in the United 
States and Europe. These studies are only a limited 
sampling, and the number of demonstrable haplotypes in 
chicken populations worldwide would probably exceed a 
hundred (Briles and Briles, 1987).
The B complex is understood to consist of three 
subregions, B-G, B-F, and B-L (Pink et al, 1977), each
coding for serologically defined antigens of differing 
tissue distribution. B-F and B-L antigens code for avian 
homologs of mammalian class I and class II antigens, 
respectively (Nordskog et al. , 1987). The B-F or class I
molecule consists of a heavy chain having an apparent 
molecular weight of 40-43 kD, and is noncovalently 
associated with a beta-2-microglobulin chain having an 
apparent weight of 11-12 kD (Ziegler and Pink, 1976). B-F is 
expressed on all somatic cells, which include the nucleated 
avian erythrocyte.
4The B-L or class II molecule is a dimer consisting of 
alpha and beta chains (Crone et al., 1981) having an 
apparent molecular weight of 27 and 32 kD, respectively 
(Ziegler and Pink, 1978). The B-L antigen, the equivalent of 
the la antigen in mice, is distributed on B cells, 
monocytes/macrophages, dendritic cells, and activated T 
cells (Hala et al., 1984).
The B-G subregion codes for a unique avian erythrocytic 
antigen, designated class IV, consisting of a 46-48 kD 
monomer in reduced form, and is expressed as an 85 kD dimer 
isolated from avian erythrocytes, or a 13 0 kD trimer 
isolated from erythrocyte membranes (Salomonsen et al., 
1987) . At present, no homologous mammalian counterpart to 
the B-G antigen has been identified (Briles and Briles, 
1987) .
The B complex has been shown to be linked to the 
nucleolus organizer region (NOR) on a medium-sized 
acrocentric chromosome of about 16th in size (Bloom and 
Bacon, 1985). Since the NOR occupies a majority of the long 
arm, Bloom and coworkers (1987) speculate that a likely 
subchromosomal location for the MHC resides on the long arm 
proximal to the centromere. Other possible locations include 
the distal long arm region, the short arm, or a pericentric 
location including both proximal long arm and short arm 
regions.
Infrequent recombinational events between the B-F and 
B-G regions have been described. Eight B-F/B-G recombinants
5have been identified with the consistent transmission of B-F 
and B-L from the same parental chromosome (Briles et al., 
1982). Moreover, gene duplication or recombination within 
the B-G subregion has been described (Miller et al., 1986). 
No recombination between B-F and B-L has yet been identified 
by serological methods suggesting that these regions may be 
tightly linked. It is possible that the limited frequency of 
recombination is directly related to the short chromosomal 
segment occupied by the avian MHC (Vainio et al., 1987). In 
addition, the B complex does not appear to contain hot spots 
of recombination as reported for the murine MHC (Steinmetz 
et al., 1986). Taken together, these findings indicate 
strong linkage disequilibrium with the transmission of 
associated B-F and B-L alleles (Simonsen et al., 1982).
The first functional description of the B complex as a 
marker for the avian MHC arose from studies examining the 
relationship of the B blood group system with skin graft 
rejection (Schierman and Nordskog, 1961). The B complex's 
association with other immune functions include graft- 
versus-host reaction (Lee and Nordskog, 1981), mixed 
lymphocyte reaction (Miggiano et al., 1974); total hemolytic 
complement (Chahn et al., 1976); immune responses to 
synthetic antigens (Benedict et al., 1975; Pevzner et al., 
1978) ; serum IgG levels (Rees and Nordskog, 1981) ; 
interleukin-2 levels (Knudston and Lamont, 1987); and PHA- 
wattle response (Taylor et al., 1987).
6The association between the B complex and disease 
resistance has been extensively reviewed (Bacon, 1987) . 
Specific B haplotypes have been shown to control resistance 
and/or susceptibility to Marek/s disease (Briles and Briles, 
1982; Briles et al., 1977; Bacon et al., 1981); sarcoma 
tumors (reviewed by Collins and Zsigray, 1984; Schierman and 
Collins, 1987) ; avian lymphoid leukosis (Bacon et al. ,
1981); and fowl cholera (Lamont et al., 1987). Studies using 
B complex recombinant chickens have permitted the mapping of 
resistance to Marek's disease (Briles et al. , 1983) and 
regression of Rous sarcoma virus-induced tumors (Auclair, 
1982; Aeed, 1984) to the B-F subregion.
Genetic variation among hosts in the response to avian 
coccidia infection is well established (Jeffers and Shirley,
1982). Recent studies have investigated the specific role of 
blood group systems on resistance to Eimeria tenella 
infection (Johnson and Edgar, 1984; Johnson and Edgar, 1986; 
and Martin et al., 1986). The B complex has been shown to 
control, in part, innate resistance and acquired immunity to 
E. acervulina and/or E. tenella (Ruff and Bacon, 1984; Clare 
et al., 1985; and Lillehoj et al., 1985).
Geneticallv-Enaineered Coccidia Vaccines
Coccidiosis is an enteric disease of domestic livestock 
causing acute morbidity resulting in reduced body weight 
gain, a decrease in feed efficiency, and some mortality. In 
the poultry industry this disease becomes economically
7relevant as costs exceed $300 million annually in product 
losses, prophylactic medication (anticoccidial compounds) 
and research (Danforth and Augustine, 1985a). Indeed the 
success of today's poultry industry and the corresponding 
inexpensive cost of poultry meat is due to the 
anticoccidials. Although current drugs are highly effective, 
the coccidia are continuously evolving parasites, and 
resistant strains appear readily. Immunomodulation through 
the use of vaccines may permit a more complete method to 
effectively control these parasites. To be successful an 
economically feasible vaccine should cost no more than 
current means of prevention, require only a single 
treatment, and ultimately improve current production 
standards. To date, the most cost-effective means of vaccine 
production may involve recombinant DNA technology.
Most of the current understanding in protozoan vaccines 
evolved from research using species of Plasmodium, etiologic 
agents of malaria. It was originally discovered that 
immunity against sporozoites could be induced by the 
injection of irradiated parasites into humans, monkeys, or 
rodents (reviewed by Nussenzweig and Nussenzweig, 1984) . 
Monoclonal antibodies to the major sporozoite surface 
antigen could also passively protect rodents from parasite 
challenge (Potocnjak et al., 1980), suggesting that high 
antibody titers to the sporozoite would block sporozoite 
invasion of hepatocytes and subsequent development. Since 
sporozoites are difficult to isolate or produce in large
8quantities, characterization and cloning of the relevant 
antigens became a more feasible approach.
The gene coding for the major surface antigen or 
circumsporozoite (CS) protein has been cloned from P. 
falciparum (Dame et al., 1984) and P. vivax (Arnot et al.,
1985) of human malaria, P. knowlesi (Ozaki et al., 1983) and
P. cvnoroolgi (Enea et al., 1984) of simian malaria, and P. 
berqhei of murine malaria (Weber et al., 1987). When 
sequenced, each of these genes consisted of a central region 
containing tandem repeats, shown to comprise an active 
epitope (Hollingdale et al., 1984). In addition, synthetic 
peptides based upon these repetitive epitopes (Ballou et 
al., 1985) or recombinant constructs in Escherichia coli 
containing these repeat sequences (Young et al., 1985) 
elicited antibodies which blocked hepatocyte invasion. The 
magnitude of protection was associated with dose, boosting, 
and the type of adjuvant administered with the constructs, 
aluminum hydroxide gel being the most effective (Mazier et 
al., 1986; Wirtz et al., 1987; Hollingdale et al., 1987).
These first candidate malarial vaccines were conceived
without regard for T cell epitopes, assuming that antibody 
titers would be sufficient for protection. Studies in mice 
demonstrated that this omission created a problem because 
only mice bearing the .I-A*3 haplotype responded to a given 
fusion protein (Del Giudice et al., 1986; Good et al.,
1986). Moreover, of nine different congenic strains of mice, 
only H-2b and H~2.k strains were high responders to the
9recombinant CS protein of P. falciparum (Good et al., 1986). 
Therefore, the immunizing ability of a candidate antigen was 
directly related to the expression of the appropriate MHC 
gene. Berzofsky and coworkers (1987) suggested a similar 
situation could occur in humans, which would limit 
considerably the usefulness of these vaccines.
• ]r ,Since H—2. mice do not respond to the repetitive 
epitope, they must recognize a T epitope outside the 
repetitive region. Studies were undertaken to identify the 
specific T epitope recognized by H-2k mice and shown to map 
to the I-Ak region (Berzofsky et al., 1987). An amphipathic
model or algorithm has been proposed to functionally 
describe a T reactive site (Margalit et al., 1987). Simply, 
the immunodominant site recognized by T cells may be an 
amphipathic structure consisting of hydrophilic and 
hydrophobic residues which align, respectively, in an alpha- 
helix (DeLisi and Berzofsky, 1985; Berzofsky et al. , 1986;
DeLisi et al., 1987; Spouge et al., 1987). The hydrophilic 
side would interact with the T cell receptor, while the 
hydrophobic side would interact with either class I or II 
MHC molecules (Berzofsky et al., 1987). An amphipathic 
structure would result from antigen processing by the 
appropriate antigen-presenting cell (APC), and would be 
stabilized by the APC surface environment (Berzofsky et al., 
1987) . Using this algorithm, a T site was predicted on the 
carboxy terminal side of the CS epitope. A corresponding 
peptide was manufactured which successfully primed H-2k
10
helper T cells for a secondary antibody response. Having 
isolated the appropriate T epitope, a synthetic immunogen 
could be created consisting of both B and T epitopes.
The phenomena of MHC-restricted responsiveness must 
still be addressed. MHC restriction describes the 
interaction between lymphocytes and/or APC's, which requires 
identity at the level of expressed MHC haplotypes. The fact 
that only a few MHC haplotypes respond to the CS antigen 
suggests that associated vaccines would be limited in their 
immunizing capabilities. A greater understanding of the 
human MHC or HLA complex, which exceeds H-2 in polymorphism, 
is necessary as well as the specific interactions of HLA 
alleles and particular vaccine epitopes. Further 
immunomodulation may be required as indicated by Kawamura 
and coworkers (1985), who showed that MHC-1inked 
unresponsiveness could be overcome by IL-2 treatment.
Immunity to the avian coccidia is understood to derive 
from a species-specific cell-mediated response augmented by 
locally produced antibody (reviewed by Rose, 1982; Powell, 
1987). Rose (1985) speculated that the host immune response 
is evoked primarily by merozoite antigens and directed 
against subsequent sporozoite invasion. Murray and coworkers 
(1985) isolated and characterized sporozoite antigens of E. 
tenella. Twenty-three polypeptides were identified by 
polyacrylamide gel electrophoresis (PAGE) , and of these 
bands, eight (235, 105, 94, 82, 71, 68, 45, and 26 kD)
reacted strongly with polyclonal sporozoite antisera raised
11
in rabbits. An extract produced from ground, sporulated 
oocysts, injected intramuscularly without adjuvant into 
chickens, caused a reduction in lesion scores following 
homologous parasite challenge. in addition, a similar 
antigen preparation from E. acervulina elicited protection 
through reduced lesion scores, against E. tenella and E. 
maxima. These findings are in direct contrast to studies 
(reviewed by Rose, 1982) which concluded that non-viable 
coccidia antigens were not immunogenic. Moreover, the 
existence of species cross-protective antigens had not been 
described previously.
Unlike Plasmodia, little information exists concerning 
a major sporozoite surface antigen (Paul et al., 1986). A 
21-23 kD polypeptide was isolated from E. tenella and used 
to produce serum antibodies in chickens which neutralized 
sporozoites in vitro. The effect of this antigen in vivo was 
not examined.
Hybridoma antibodies have been used extensively to 
characterize both species- and stage-specific coccidia 
antigens (Wisher, 1983; Danforth, 1985; Truitt et al. 1986). 
E. tenella has probably been characterized the most 
thoroughly, including monoclonal antibodies (MAb) raised 
against sporozoite surface antigens (McAndrew et al., 1986), 
both sporozoites and merozoites (Danforth and McAndrew,
1987), and microgametocytes (Laxer et al., 1987). Although 
several of these MAb have been shown to neutralize parasite
12
stages in vitro, none have been shown to elicit passive 
protection in vivo.
The promise of a genetically-engineered malarial 
vaccine has encouraged work toward the production of a 
similar vaccine for the coccidia (reviewed by Danforth and 
Augustine, 1988). Cloning technology has enabled the
production of cDNA libraries for E. tenella sporozoites 
and/or merozoites (Danforth and Augustine, 1985b; Binger et 
al., 1986; Clarke et al., 1986). Stage-specific MAb have 
been used to screen these libraries, and a few recombinant 
antigens have been isolated and tested in vivo.
One of these proteins, designated 5401, was cloned from 
sporulated E. tenella oocysts and has an apparent molecular 
weight of 35 kD (Danforth and Augustine, 1988) . 5401
contains a nine amino acid sequence consisting of Ala-Glu- 
Glu-Leu-Pro-Gly-Glu-Glu-Gly, which is repeated five times. 
Following subcutaneous injection along with adjuvant into 
birds, 5401 elicits serum antibodies which produce a 
surface-internal fluorescent pattern on air-dried sporo­
zoites. Protein 5401, given at doses of 2.4-4.8 ug per bird, 
also induced partial protection against a 25,000 oocyst 
challenge, although this protection could b^ overwhelmed by 
a challenge of 300,000 or more oocysts. When the 5401 gene 
was expressed in another vector, designated 3264, it induced 
protection in terms of reduced lesion scores at this higher 
challenge dose (Danforth and Augustine, unpublished
13
results). Neither protein, however, elicited any cross­
species protection with E. acervulina.
These immunity trials with 5401 and 3264 are 
encouraging with respect to producing a genetically- 
engineered coccidial vaccine. Several problems exist, 
however, which must be addressed before an effective vaccine
will be marketed. Similar to the first cloned malarial
antigens, these coccidia antigens have been characterized 
only by antibody or B cell recognition. Since B cell 
epitopes do not appear to be sufficient, reactive T cell
epitopes must be explored and identified. The amphipathic
algorithm previously mentioned could be useful in predicting 
reactive T sites in the cloned gene products.
The lack of species-cross reactive antigens identified 
to date presents a problem since nine species of chicken 
coccidia exist. Conceivably, a vaccine would have to be made 
for each one, a consequence which could severely limit the 
practicality of this cloning approach. The work reported by 
Murray and coworkers (1985) shows promise in this area since 
E. acervulina antigens were cross-protective against E. 
maxima and E. tenella. Little recombinant work has been done 
with species other than E. tenella. and possibly other 
species may provide a more complete antigen.
Finally, the host response cannot be ignored. Host 
immunity is a manifestation of several complex cellular 
events integrated and controlled by molecules encoded by the 
MHC. Malarial research has shown that only a few H-2
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haplotypes respond to certain CS antigens. This same 
phenomenon may be occurring in chickens since certain B 
haplotypes have been shown to respond differently to the E. 
tenella parasite (Clare et al., 1985). Only recently have 
highly inbred congenic populations of chickens been 
available to study directly the interaction of a given B 
allele and the expression of immunity elicited by cloned 
antigens. These congenic chickens are produced by the 
sequential backcrossing of a donor line, which supplies the 
differential gene(s) or in this case the B complex, on a 
highly inbred recipient line. This mating scheme produces 
birds whose genomes differ only at the region of the MHC. 
Since congenic chickens which differ in g complex genotype 
possess identical background gene complements, differential 
immune responsiveness may be attributable to the expressed 
MHC alleles. Information gained from this type of research 




Aeed, P.A. 1984. Characterization of the anti-Rous sarcoma 
response of B-F/B-G recombinants on different B complex 
backgrounds, and failure to produce recombinants 
between the B-L and B-F chromosomal segments. Master of 
Science Thesis, Library, University of New Hampshire, 
Durham, New Hampshire 03824.
Arnot, D.E., J.W. Barnwell, J.P. Tam, V. Nussenzweig, R. 
Nussenzweig, and V. Enea. 1985. Circumsporozoite 
protein of Plasmodium vivax: Gene cloning and
characterization of the immunodominant epitope. Science 
230:815-818.
Auclair, B.W. 1982. Major histocompatibility complex 
recombinants and a whole blood phytohemagglutinin assay 
for the investigation of genetic and immunological 
control of RSV-induced tumors in chickens. Master of 
Science Thesis, Library, University of New Hampshire, 
Durham, New Hampshire 03824.
Bccon, L.D. 1987. Influence of the major histocompatibility 
complex on disease resistance and productivity. Poultry 
Sci. 66:802-811.
Bacon, L.D., R.L. Witter, L.B. Crittenden, A. Fadly, and J. 
Motta. 1981. B-Haplotype influence on Marek's disease, 
Rous sarcoma and lymphoid leucosis virus-induced tumors 
in chickens. Poultry Sci. 60:1132-1139.
Ballou, W.R., J, Rothbard, R. A. Wirtz, D.M. Gordon, J.S. 
Williams, R.W. Gore, I. Schneider, M.R. Hollingdale, 
R.L. Beaudoin, R.L. Maloy, L.H. Miller, and T. 
Hockmeyer. 1985. Immunogenicity and biologic activity 
of antibodies to synthetic peptides of the circum­
sporozoite protein of Plasmodium falciparum. Science 
228:996-999.
Benedict, A.A., L.W. Pollard, P.R. Morrow, H.H. Abplanalp, 
P.H. Mauer, and W.E. Briles. 1975. Genetic control of 
immune responses in chickens. I. Responses to a ter- 
polymer of poly (Glu60Ala30Tyrl0) associated with the 
major histocompatibility complex. Immunogenetics 2:313- 
324.
16
Berzofsky, J.A. , K.B. Cease, J.L. Cornette, J.L. Spouge, H. 
Margalit, I.J. Berkower, M.F. Good, L.H, Miller, and C. 
DeLisi. 1987. Protein antigenic structures recognized 
by T cells: Potential applications to vaccine design.
Immunol. Rev. 98:9-52.
Berzofsky, J.A. , J. Cornette, H. Margalit, I. Berkower, K. 
Cease, and C. DeLisi. 1986. Molecular features of Class 
II MHC-restricted T cell recognition of protein and 
peptide antigens: the importance of amphipathic
structures. Curr. Top. Microbiol. Immunol. 13 0:14-2 4.
Binger, M.H., S.J. McAndrew G. Schildknecht. 1986. Cloning
and expression of E. tenella merozoite cDNA. J. Cell. 
Biochem. 10A:144.
Bloom, S.E and L.D. Bacon. 1985. Linkage of the major 
histocompatibility (B) complex and the nucleolar 
organizer in the chicken: Assignment to a micro­
chromosome. J. Hered. 76:14 6-154.
Bloom, S.E.-, W.E. Briles, R.W. Briles, M.E. Delany, and R.R. 
Dietert. 1987. Chromosomal localization of the major 
histocompatibility (B) complex (MHC) and its expression 
in chickens aneuploid for the major histocompatibility 
complex/ribosomal deoxyribonucleic acid microchromo­
some. Poultry Sci. 66:782-789.
Briles, W.E. and R.W. Briles. 1982. Identification of 
haplotypes of the chicken major histocompatibility 
complex (B). Immunogenetics 15:449-459.
Briles, W.E. and R.W. Briles. 1987. Genetics and 
classification of major histocompatibility complex 
antigens of the chicken. Poultry Sci. 66:776-781.
Briles, W.E., R.W. Briles, R.E. Taffs, and H.A. Stone. 1983. 
Resistance to a malignant lymphoma is mapped to 
subregion of major histocompatibility (B) complex. 
Science 219:977-979.
Briles, W.E., N. oumstead, D.L. Ewert, D.G. Gilmour, J. 
Gogusev, K. Hala, C. Koch, B.M. Longenecker, A.W. 
Nordskog, J.R.L. Pink, L.W. Schierman, M. Simonsen, A. 
Toivanen, P. Toivanen, O. Vainio, and G. Wick. 1982. 
Nomenclature for major histocompatibility (B) complex. 
Immunogenetics 15:441-447.
Briles, W.E., W.H. McGibbon, and M.R. Irwin. 1950. On 
multiple alleles affecting cellular antigens in the 
chicken. Genetics 35:633-652.
17
Briles, W.E., H.A. Stone, and R.K. Cole. 1977. Marek's 
disease: effects of B histocompatibility alloalleles in 
resistant and susceptible chicken lines. Science 
195:193-195.
Chahn, T.C., A.A. Benedict, H.H. Abplanalp. 1976. 
Association of serum hemolytic complement levels with 
the major histocompatibility complex in chickens. J. 
Exp. Med. 144:555-561
Clare, R.A., R.G. Strout, R.L. Taylor, Jr., W.M. Collins, 
and W.E. Briles. 1985. Major histocompatibility (B) 
complex effects on acquired immunity to cecal 
coccidiosis. Immunogenetics 22:593-599.
Clarke, L.E., L.I. Messer, and M.H. Wisher. 1986. Antigens 
of Eimeria cloned and expressed in E. coli■ J. Cell. 
Biochem. 10A:145.
Collins, W.M. and R.M. Zsigray. 1984. Genetics of the 
response to Rous sarcoma virus-induced tumours in 
chickens. Anim. Blood Groups Biochem. Genet. 15:159- 
171.
Crone, M., J. Jensenius, and C. Koch. 1981. Evidence for two 
populations of B-L (la-like) molecules encoded by the 
chicken MHC. Immunogenetics 13:381-391.
Dame, J.B., J.L. Williams, T.F. McCutchan, J.L. Weber, R.A. 
Wirtz, W.T. Hockmeyer, W.L. Maloy, D.H. Haynes, I. 
Schneider, D. Roberts, G.S. Sanders, E.P. Reddy, C.L. 
Diggs, and L.H. Miller. 1984. Structure of the gene 
encoding the immunodominant surface antigen on the 
sporozoite of the human malaria parasite Plasmodium 
falciparum. Science 225:593-599.
Danforth, H.D. 1985. Use of hybridoma antibodies combined 
with genetic engineering in the study of protozoan 
parasites: A review. In: Research in Avian Coccidiosis, 
eds. L.R. McDougald, L.P. Joyner, P.L. Long, University 
of Georgia, Department of Poultry Science, Athens, GA. 
pp. 574-590.
Danforth, H.D. and P.C. Augustine. 1985a. Avian coccidiosis 
vaccine: A first step. Animal Nutrition and Health,
August, pp. 18-21.
Danforth, H.D. and P.C. Augustine. 1985b. Use of hybridoma 
antibodies and recombinant DNA technology in protozoan 
vaccine development. Avian Dis. 30:37-42.
Danforth, H.D. and P.C. Augustine. 1988. Coccidia vaccines. 
In: Veterinary Protozoan and Hemoparasite Vaccines, ed. 
I.G. Wright. CRC Press, Boca Raton, FL. IN PRESS.
18
Danforth, H.D. and S.J. McAndrew. 1987. Hybridoma antibody 
characterization of stage-specific and stage-reactive 
antigens of Eimeria tenella. J. Parasitol. 73:985-992.
Del Guidice, G. , J.A. Cooper, J. Merino, A.S. Verdini, A. 
Pessi, A.R. Togna, H.D. Engers, G. Corradin, and P.H. 
Lambert. 1986. The antibody response in mice to 
carrier-free synthetic polymers of Plasmodium 
falciparum circumsporozoite repetitive epitope is I-A- 
restricted: possible implications for malaria vaccines. 
J. Immunol. 137:2952-2955.
DeLisi, C. and J.A. Berzofsky. 1985. T-cell antigenic sites 
tend to be amphipathic structures. Proc. Natl. Acad. 
Sci. USA 82:7048-7052.
DeLisi, C. , J. Cornette, H. Margalit, K. Cease, J. Spouge, 
and J.A. Berzofsky. 1987. The role of amphipathicity as 
an indicator of T cell antigenic sites on proteins. In: 
Immunogenicity of Protein Antigens: Repertoire and
Regulation, eds. E. Sercarz and J.A. Berzofsky. CRC 
Press, Boca Raton, FL. IN PRESS.
Enea, V., D. Arnot, E.C. Schmidt, A. Cochrane, R. Gwadz, and 
R.S. Nussenzweig. 1984. Circumsporozoite protein gene 
of Plasmodium CYnomolai (Gombak). Proc. Natl. Acad. 
Sci. USA 81:7520-7524.
Good, M.F., J.A. Berzofsky, W.L. Maloy, Y. Hayashi, N. 
Fujii, W.T. Hockmeyer, and L.H. Miller. 1986. Genetic 
control of the immune response in mice to a Plasmodium 
falciparum sporozoite vaccine: Widespread non
responsiveness to single malaria T epitope in highly 
repetitive vaccine. J. Exp. Med. 164:655-660.
Hala, K. , G. Wick, R.L. Boyd, H. Wolf, G. Bock and D.L. 
Ewert. 1984. The B-L (Ia-like) antigens of the chicken. 
Lymphocyte plasma membrane distribution and tissue 
localization. Dev. Comp. Immunol. 8:673-682.
Hollingdale, M.R., W.R. Ballou, S.B. Aley, J.F. Young, S. 
Pancake, L.H. Miller, and W.T. Hockmeyer. 1987.
Plasmodium falciparum: Elicitation by peptides and
recombinant circumsporozoite proteins of circulating 
mouse antibodies inhibiting sporozoite invasion of 
hepatoma cells. Exp. Parasitol. 63:345-351.
Hollingdale, M.R., E.H. Nardin, S. Tharavanij, A.L.
Schwartz, and R.S. Nussenzweig. 1984. Inhibition of 
entry of Plasmodium falciparum and P. vivax sporozoites 
into cultured cells; an in vitro assay of protective 
antibodies. J. Immunol. 132:909-913.
19
Jeffers, T.K. and M.W. Shirley. 1982. Genetics, specific and 
intraspecific variation. In: The Biology of the
Coccidia. P.L. Long, ed. University Park Press,
Baltimore, pp.63-100.
Johnson, L.W. and S.A. Edgar. 1984. Ea-A and Ea-E cellular
antigen genes in Leghorn lines resistant and
susceptible to acute cecal coccidiosis. Poultry Sci. 
63;1695-17 04.
Johnson, L.W. and S.A. Edgar. 1986. Ea-B and Ea-C cellular
antigen genes in Leghorn lines resistant and
susceptible to acute caecal coccidiosis. Poultry Sci. 
65:241-252.
Kawamura, H. , S.A. Rosenberg, and J.A. Berzofsky. 1985. 
Immunization with antigen and interleukin-2 in vivo 
overcomes Ir genetic low responsiveness. J. Exp. Med. 
162:381-386.
Knudston, K.L. and S.J. Lamont. 1987. Genetic associations 
of interleukin-2 levels in chickens. Poultry Sci.
66(Suppl.1):127.
Lamont, S.J., C. Bolin, and N. Cheville. 1987. Genetic
resistance to fowl cholera is linked to the major 
histocompatibility complex. Immunogenetics 25:284-289.
Laxer, M.A . , M.C. Healey, and N.N. Youssef. 1987. Production 
of monoclonal antibodies specific for Eimeria tenella 
microgametocytes. J. Parasitol. 73:611-616.
Lee, R.W.H. and A.W. Nordskog. 1981. Role of the immune-
response region of the B complex in the control of the 
graft-vs-host reaction in chickens. Immunogenetics 
13:85—92.
Lillehoj, H.S., P.C. Allen, and M.D. Ruff. 1985. Comparative 
studies of humoral and cellular immune responses in two 
inbred strains of chickens showing different 
susceptibility to coccidiosis. In: Research ir. avian
coccidiosis. L.R. McDougald, L.R. Joyner, P.L. Long, 
eds. Univ. of Georgia, Athens, GA. pp.470-481.
Margalit, H. , J.L. Spouge, J.L. Cornette, K.B. Cease, C. 
DeLisi, and J.A. Berzofsky. 1987. Prediction of 
immunodominant helper T cell antigenic sites from the 
primary sequence. J. Immunol. 138:2213-2229.
Martin, A., W.B. Gross, E.A. Dunnington, R.W. Briles, W.E.
Briles, and P.B. Siegal. 1986. Resistance to natural
and controlled exposures to Eimeria tenella: Genetic
variation and alloantigenic systems. Poultry Sci. 
65:1847-1852.
20
Mazier, D., S. Mellouk, R.L. Beaudoin, B. Texier, P. 
Druilhe, W. Hockmeyer, J. Trosper, C. Paul, Y. 
Charoenvit, J. Young, F. Miltgen, L. Chedid, J.P. 
Chigot, B. Galley, O. Brandicourt, and M. Gentilini. 
198 6. Effect of antibodies to recombinant and synthetic 
peptides on P. falciparum sporozoites in vitro. Science 
231:156-159.
McAndrew, S.J., T. Truitt, G. Schildknecht, M.H. Binger, M. 
Griffin, and R. Chizzonite. 1986. Characterization of 
Eimeria sporozoite surface antigens with monoclonal 
antibodies. J. Cell. Biochem. 10A:149.
Miggiano, V.C., I Birgen, and J.R.L. Pink. 1974. The mixed 
leukocyte reaction in chickens. Evidence for control by 
the major histocompatibility complex. Eur. J. Immunol. 
4:397-401.
Miller, M.M., R. Goto, and W.E. Briles. 1986. Biochemical 
evidence for recombination within the B-G region of the 
chicken major histocompatibility complex. Poultry Sci. 
65(Suppl. 1):94.
Murray, P.K. , B.S. Bhogal, M. St. J. Crane, and T.T. 
MacDonald. 1985. Eimeria tenella-in vivo immunization 
studies with sporozoite antigen. In: Research in Avian 
Coccidiosis, eds. L.R. McDougald, L.P. Joyner, P.L. 
Long, University of Georgia, Department of Poultry 
Science, Athens, GA. pp. 564-573.
Nordskog, A.W., I.Y. Pevzner, and S.J. Lamont. 1987. 
Subregions and functions of the chicken major 
histocompatibility complex. Poultry Sci 66:790-794.
Nussenzweig, R.S. and V. Nussenzweig. 1984. Development of 
sporozoite vaccines. Philos. Trans. R. Soc. London 
Biol. 307:117-128.
Ozaki, L.S., P. Svec, R.S. Nussenzweig, V. Nussenzweig, and 
G.N. Godson. 1983. Structure of the Plasmodium knowlesi 
gene coding for the circumsporozoite protein. Cell 
34 :815—822.
Paul, L.S., V.M. Brothers, J.G. Files, J.L. Tedesco, K.Z. 
Newman, and T.C. Gore. 1986. Purification and 
characterization of a major surface antigen of Eimeria 
tenella. J. Cell. Biochem. 10A:169.
Pevzner, I.Y., C.L. Trowbridge, and A.W. Nordskog. 1978. 
Recombination between genes coding for immune response 
and serologically determined antigens in the chicken B 
system. Immunogenetics 7:25-33.
21
Pink, J.R.L-, W- Droege, K. Hala, V.C. Miggiano, and A. 
Ziegler. 1977. A three-locus model for the chicken 
major histocompatibility complex. Immunogenetics 5:203- 
216.
Potocnjak, P., N. Yoshida, R.S. Nussenzweig, and V. 
Nussenzweig. 1980. Monovalent fragments (Fab) of 
monoclonal antibodies to sporozoite surface antigen 
(Pb44) protect mice against malarial infection. J. Exp. 
Med. 151:1504-1513.
Powell, P.C. 1987. Immune mechanisms in infections of 
poultry. Vet. Immunol. Immunopath. 15:87-113.
Rees, M.J. and A.W. Nordskog. 1981. Genetic control of serum 
immunoglobulin G levels in the chicken. J. Immunogenet. 
Oxj. 8:425-431.
Rose, M.E. 1982. Host immune responses. In: The Biology of
the Coccidia, ed. P.L. Long. University Park Press. 
Baltimore, MD. pp.330-371.
Rose, M.E. 1985. Immune responses to Eimeria infection. In:
Research in Avian Coccidia, eds L.R. McDougald, L.P.
Joyner, and P.L. Long. University of Georgia, 
Department of Poultry Science, Athens, GA. pp. 449-469.
Ruff, M.D. and L.D. Bacon. 1984. Coccidiosis in 15.B
congenic chicks. Poultry Sci. 63(Suppl. 1):172-173.
Salomonsen, J., K. Skjodt, M. Crone, and M„ Simonsen. 1987. 
The chicken erythrocyte-specific MHC antigen. 
Characterization and purification of the B-G antigen by 
monoclonal antibodies. Immunogenetics 25:373-382.
Schierman, L.W. and W.M. Collins. 1987. Influence of the 
major histocompatibility complex on tumor regression 
and immunity in chickens. Poultry Sci. 66:812-818.
Schierman, L.W. and A.W. Nordskog. 1961. Relationship of 
blood type to histocompatibility in chickens. Science 
134:1008-1009.
Simonsen,M. , M. Crone, C. Koch, and K. Hala. 1982. The MHC 
haplotypes of the chicken. Immunogenetics 16:513-53 2.
Spouge, J.L., H.R. Guy, J.L. Cornette, H. Margalit, K. 
Cease, J.A. Berzofsky, and C. DeLisi. 1987. Strong
conformational propensities enhance T-cell antigeni­
city. J. Immunol. 138:204-212.
Steinmetz, M. , D. Stephan, and K.F. Lindahl. 1986. Gene 
organization and recombinational hotspots in the murine 
major histocompatibility complex. Cell 44:895-904.
22
Taylor, R.L., Jr., P.F. Cotter, T.L. Wing, and W.E. Briles. 
1987. Major histocompatibility (B) complex and sex 
effects on the phytohemagglutinin wattle response. 
Anim. Genet. 18:343-500.
Truitt, T. , S.J. McAndrew, M. Griffin, M.H. Binger, and R. 
Chizzonite. 1986. Surface antigens of the parasitology 
species Eimeria: Characterization and developmental
appearance. Hybridoma 5:85.
Vainio, O., P. Vainio, and A. Toivanen. 1987. Major histo­
compatibility complex and cell cooperation. Poultry 
Sci. 66:795-801.
Weber, J.L., J.E. Egan, J.A. Lyon, R.A. Wirtz, Y. 
Charoenvit, W.L. Maloy, and W.T. Hockmeyer. 1987. 
Plasmodium berghei: Cloning of the circumsporozoite
gene. Exp. Parasitol. 63:295-300.
Wirtz, R.A., W.R. Ballou, I. Schneider, L. Chedid, M.J, 
Gross, J.F. Young, M. Hollingdale, C.L. Diggs, and W.T. 
Hockmeyer. 1987. Plasmodium falciparum: Immunogenicity
of circumsporozoite constructs produced in Escherichia 
coli. Exp. Parasitol. 63:166-172.
Wisher, M.H. 1983. Characterization of the antigens of 
Eimeria species. Parasitology 87:8.
Young, J.F., W.T. Hockmeyer, M.T. Gross, W.R. Ballou, R.A. 
Wirtz, J.H. Trosper, R.L. Beaudoin, M.R. Hollingdale, 
L.H. Miller, C.L. Diggs, and M. Rosenberg. 1985. 
Expression of Plasmodium falciparum circumsporozoite 
proteins in Escherichia coli for potential use in a 
human malaria vaccine. Science 228:958-962.
Ziegler, A. and R. Pink. 1976. Chemical properties of two 
antigens controlled by the major histocompatibility 
complex of the chicken. J. Biol. Chem 251:5391-5396.
Ziegler, A. and R. Pink. 1978. Structural similarities of 
major histocompatibility antigens on leukocytes and 
erythrocytes. Immunochemistry 15:515-516.
CHAPTER ONE
Characterization of Resistance and Immunity 
to Eimeria tenella Among 





The relative influence of the 3-F vs. B-G chromosomal 
regions on innate resistance and immunity to Eimeria tenella 
was studied among six B-F/B-G recombinants, designated BR1, 
br3, BR4, BR5, br6, and BR8. In one experiment, resistance 
was studied among 340 F 2  chicks, each carrying the B17 
allele derived from line UCD.003, and therefore also 
heterozygous for one of the B recombinant haplotypes. In a 
second experiment, acquired immunity was studied among 161 
F2 chicks each carrying one B^7 allele, and segregating for 
one of the recombinant alleles.
In Experiment 1, Fj chicks of similar haplotypes, BR3 
and BR4 (BF2-G23), gained significantly more weight than 
those with BR1 (qF24-G23j and gR5 q^F21-G19j following
exposure to a single high dose of 2 5,000 oocysts, although 
no differences in lesion scores were detected among the six 
recombinants. Following exposure to a single low dose of 
2 500 oocysts, F2  chicks BR3 and BR4 also gained 
significantly more weight and had significantly lower lesion 
scores compared to BR1 or BR5 chicks. On the other hand, 
when all six heterozygous recombinants were immunized with a 
single exposure of 2500 oocysts followed by challenge with
10,000 oocysts 21 days later, BR5 chicks had the lowest mean 
lesion scores. To study acquired immunity in the F2 
homozygous chicks, five consecutive daily exposures of 500 
oocysts were followed 21 days later by challenge with 10,000 
oocysts. BR5 (bF21-g19) and SR6 (bF21-G23) homozygous
25
chicks, both carrying the B-F21 allele, showed significant 
protection in terms of reduced lesion scores. These results 
suggest that the B-F chromosomal subregion imparts some 
control over the mechanism of innate resistance and also 
acquired immunity to E. tenella.
KEY WORDS: Coccidiosis, Eimeria. B complex recombinants
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Introduction
Genetic variation among hosts in the response to avian 
coccidia infection is well established (Jeffers and Shirley, 
1982). More recent studies have investigated the specific 
role of blood group system genes on resistance to Eimeria 
tenella infection (Johnson and Edgar, 1986? Martin et al. . 
1986; and Johnson Edgar, 1984). The I| blood group system, 
discovered by Briles and coworkers (1950) and established as 
the marker for the chicken major histocompatibility complex 
(Schierman and Nordskog, 1961), has been shown to control, 
in part, innate resistance and acquired immunity to E. 
acervulina or E. tenella (Ruff and Bacon, 1984; Lillehoj et 
al., 1985; Clare et al., 1985).
The B complex is understood to consist of three 
subregions, B-G. B-F. and B-L (Pink et al, 1977) , each 
coding for serologically defined antigens of differing 
tissue distribution. B-F and B-L antigens code for avian 
homologs of mammalian class I and class II antigens, 
respectively. The B-G subregion codes for a unique avian 
erythrocytic antigen, having no homologous mammalian 
counterpart. No recombination between B-F and B-L has yet 
been identified in progeny from experimental matings by 
serological methods, suggesting that these subregions are 
very tightly linked. Studies using B-F/B-G recombinant 
chickens have permitted the mapping of resistance to Marek's 
disease (Briles et a^., 1983) and regression of Rous sarcoma
27
virus-induced tumors (Auclair, 1982; Aeed, 1984) to the B-F 
subregion.
The present study examines the relative influence of 
the B-F and B-G chromosomal regions on innate resistance 
and immunity to E. tenella. among six B complex 
recombinants, designated BR1, BR3, BR4, BR5, BR6, and BR8.
Materials and Methods
Experiment 1. Two hatches totaling 340 F^ generation 
chicks were produced from single sire matings designed to 
place each of the six B-F/B-G recombinant haplotypes on a 
line UCD.003 (B17B17) background. Therefore, all chicks
produced from each of the six matings were either full-sibs 
or half-sibs. At 5 weeks of age, chicks heterozygous for 
each separate recombinant were divided among three treatment 
groups to receive the following primary inocula of E. 
tenella: 25,000 oocysts, 2500 oocysts, and uninfected
controls. The Lilly 65 strain of E. tenella was used 
throughout this study. Twice as many chicks were included in 
groups exposed to 2500 oocysts and uninfected controls as in 
the group exposed to 25,000 oocysts. Half of the chicks in 
the former groups were challenged with 10,000 oocysts 21 
days after the primary exposure. Cecal lesion scores 
(Johnson and Reid, 1970), prepatent body weight gain, and 
percent mortality were measured 6 days following both 
primary and secondary exposures.
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Experiment. 2. Adults of each of four heterozygous 
genotypes B17£R3, B17BR5, b17Br6, and Bl7BR8 resulting from 
matings in Experiment 1 were segregated into single sire 
breeding groups. The progeny of each of the four groups 
consisted of sib and half-sib individuals homozygous for 
recombinant BR3, IJR5, BR6, or BR8 together with sibs and 
half-sibs heterozygous for the respective recombinants 
(BR3B17, etc.) and homozygous for the haplotype B17. A total 
of 161 F2 chicks were placed on experiment. At five weeks of 
age, chicks of each of these B haplotype combinations were 
immunized with 500 E. tenella oocysts for each of five 
consecutive days. Unimmunized chicks from each mating type 
were maintained as controls. Twenty-one days following the 
last 500 oocyst exposure, all chicks were challenged with
10,000 oocysts. Cecal lesion scores and prepatent body 
weight gain were determined 6 days following the challenge 
exposure.
All birds were typed at 2 weeks of age for B locus 
alloantigens by hemagglutination (Briles and Briles, 198 2; 
Briles, unpublished). Data were analyzed by analysis of 
variance for genotype and treatment effects, as well as for 
any genotype x treatment interaction. Means were separated 
using Fisher's protected LSD test at P<0.05.
Results
Experiment l. B17 heterozygotes possessing serologi­
cally similar haplotypes BR3 and BR4 (both bF2_G23) gained
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significantly more weight than those with BR1 (bF24“G23) and 
jjR5 q^F21-G19j following exposure to 25,000 oocysts, 
although no significant differences in lesion scores were 
detected among the six recombinants (Table 1). The 25,000 
oocyst exposure produced a severe infection as indicated by 
cecal lesion scores averaging between 3.6 and 4.0 as well as 
high mortality. Such a heavy infection may have overwhelmed 
any genetic effect upon innate resistance.
A more distinct genotype effect on resistance was shown 
following the exposure to 2500 oocysts. BR3 and BR4 gained 
significantly more weight and had significantly lower lesion 
scores than BR1 and BR5 (Table 1). Although BR6 (bF21-G23) 
and BR8 (gF2-G2,23j exhibited greater weight gains at each 
exposure level than did BR1 and gR5, both manifested the 
highest lesion scores following 2500 oocysts. Only 5% of BR6 
chicks died as a result of the lower dose (data not shown).
No significant differences among genotypes in either 
lesion score or weight gain following the secondary 10,000 
oocyst challenge were detected (Table 2). Chicks previously 
exposed to 2500 oocysts had reduced lesion scores compared 
to susceptible controls.
Experiment 2. Homozygous bR5BR5 chicks had 
significantly lower lesion scores following challenge than 
either bR3BR3 or BR8BR8 homozygotes, while homozygous bR6BR6 
chicks had significantly lower lesion scores than BR8BR8 
chicks (Table 3). Both BR5BR5 and BR6BR6 chicks had
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significantly lower lesion scores than their respective 
unimmunized controls while BR3BR3 and bR8br8 chicks did not.
Heterozygotes b 17br  ^ and B17BR6 (Table 3) had signifi­
cantly lower lesion scores than their respective controls, 
although neither differed significantly from either B17BR3 
or B17BR8. Among the B17B17 homozygotes, the segregants from 
the B mating showed for significant protection to 
challenge and significantly lower lesion scores than B17B17 
segregants from either BR5 or BR6 matings.
Immunized chicks gained significantly more weight 
following challenge than respective unimmunized controls 
(Table 4). No significant effect of B genotype on weight 
gain was measured among the recombinant BRBR homozygotes or 
the B17BR heterozygotes. The B17B17 segregants from the BR3 
mating did gain significantly more weight than the B17B17 
segregants from the BR5 mating, an effect paralleling the 
magnitude of protection also seen with reduced cecal 
lesions.
Discussion
These data suggest that different genetic mechanisms 
may be involved with innate resistance to cecal coccidiosis 
as compared to acquired immunity. Recombinant chicks 
possessing the B-F2 segment from the haplotype B2 (Briles 
and Briles, 1977; Briles and Briles, 1980) exhibited greater 
innate resistance to E. tenella parasitism, but after 
priming showed little protection against a challenge
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infection. Conversely, chicks carrying the B-F21 segment of 
the haplotype B21 (Briles et al., 1983) were susceptible to 
an initial exposure, but following immunization were 
protected against a challenge infection. Therefore, the 
B-F2 segment was associated with resistance, while the B-F21 
segment was associated with acquired immunity. Taken 
together, these findings confirm previous studies (Aeed, 
1984; Auclair, 1982; Briles et al., 1983) which implicate
the B-F subregion as having a definite role in disease 
susceptibility.
While the recombinant BRS possesses the chromosome 
segments B-F2 and B-G2 3 in addition to B-G2a (Briles et al., 
1982; Miller et al. , 1987; Briles, unpublished), these
chicks did not show the same protective response to the 
initial exposure as did serologically similar BR3 and BR4 
chicks also possessing B-F2 and B-G2 3. These data suggest 
that BR8 chickens were not as resistant as BR3 and BR4 
chickens and may indicate an influence of the B-G subregion.
Previous studies in this and other laboratories 
(Davis et al. , 1985) have shown that repeated low dose
exposures of oocysts induce greater immunity to challenge 
than a single inoculation; a differential B genotype effect 
was shown following such an immunizing protocol (Clare et 
al., 1985). In Experiment 1, a single primary inoculum of
2500 oocysts induced equal protection to challenge among the 
six recombinants tested. However, all recombinants used in 
this experiment were Fx progeny, and therefore 50% of their
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genetic composition came from inbred line UCD.003. This may 
explain the uniformity of response to the challenge 
exposure.
Experiment 2 used F2 chicks segregating at the B locus 
for both the recombinant haplotype and B17. This protocol 
permitted an evaluation of recombinant haplotypes expressed 
in the heterozygote condition as in Experiment l, and also a 
comparison of br br and B17B17 homozygotes. Five consecutive 
daily exposures of 500 oocysts produced a protective 
response to challenge in BR5 and BR6 homozygotes, B17BR5 and 
B17BR6 heterozygotes, and all B17B17 homozygotes. These 
results support a role for the B-F21 allele and suggest that 
B-F17. from the B17 haplotype contributed by line UCD.003, 
also influences acquired immunity to E. tenella. In 
addition, since all progeny were produced from single-sire 
matings, individual sire effects may be contributing to the 
differential response to parasitism.
The present findings continue to support previous work 
implicating a general role for B alloantigens in controlling 
resistance or immunity to coccidiosis (Ruff and Bacon, 1984? 
Lillehoj et a^. , 1985; Clare et al. , 1985). All of these
investigations found the response to parasite infection was 
associated with the expression of a specific B haplotype. In 
contrast, studies completed by Johnson and Edgar (1984) 
described the frequencies of A and E blood group system 
haplotypes expressed in the the R and S Auburn White Leghorn 
lines, which were selected for resistance and
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susceptibility, respectively, to cecal coccidiosis (Johnson 
and Edgar, 1982) . The R line possessed two AE allele 
combinations in high frequency as opposed to completely 
different AE alleles being expressed in the S line. These 
investigators concluded that the interaction of A and E was 
necessary for these loci to factor in genetic resistance to 
E. tenella. In addition, the frequencies of B and C blood 
group system alleles in these lines were examined (Johnson 
and Edgar, 1986) , and collectively, A, E, c, and B 
alloantigen systems appear to influence mortality and body 
weight gain in response to cecal coccidiosis. Therefore, it 
seems that at least three alloantigen systems in addition to 
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TABLE 1. Mean_cecal lesion .scores. mean bo.dy_ weight gain and percent mortality 6 days 
















a17/iM (F2-G23) 22 3.9 + .lnS 24 + 3° 38 2.8 + .2a 39 + 2C
b 17/b r4 (F2-G23) 22 3.6 i .2 29 + 3° 23 2.8 ± .2a 42 + 2C
b 17/b r8 (F2-G2af23) 14 4.0 + 0 21 + 4bc 43 3.5 ± .lbc 32 + 4bc
B17/&R1 (F24-G23) 14 3.6 + .6 -20 ± 9a 7 3.3 + .2bc 25 + 4ab
B17/b r6 CF21-G23) 21 4.0 + 0 16 +
^bc 48 3.5 + .2C 40 + 3'
b 17/br5 (F21-G19) 21 3.6 + .2 6 + 6b 38 3.2 + .2b 15 + 8a
cib CMeans within columns not followed by a common letter are significantly different at
P^O.05.
nsnot significant
TABLE 2. Mean cecal_lesion scores, and _mean_faQdy .weight _gain of__B_genatypes 6 days 
following a__sesonclarv 10.000 oocyst challenge exposure given 21 days after an 
immunizing dose of 25Q0 oocysts
No. of Lesion Weight Lesion Weight
Genotype chicks score gain (g) score gain (g)
(Primed) (Naive)
B1 /b r3
(F2-G23) 21 1.4 i .3ns 56 + 5ns 3.7 + .lnS 62 +
i
CQI /b r4
(F2-G23) 22 1.2 + .3 53 + 3 3.2 + .2 63 +
B1 /b r8
(F2-G2a,23) 15 1.9 + .3 50 + 4 3.1 ± .2 48 +
B1 /b r1 (F24-G23) 16 1.3 ± .3 56 + 3 3.1 + . 2 55 +
B1 /br6 (F21-G23) 17 1.5 + . 2 53 + 4 3.5 + .2 58 +
B1 /br5 (F21-G19) 20 1.2 + . 2 50 + 3 3.3 + .2 64 +
nsnot significant
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TABLE 3. Mean cecal lesion scores of B genotypes 6 days 
following a 10.000 E. tenella oocvst challenge given 21 days 











BrBr 2.8 + .6bc 3.4 + .3° 1.4 + .4a 1.9 + . 6aI
(9) (11) (11) (9)
b 17Br 2 . 7  4- , 4 b c 2 . 7  +  .5bc 1.9 + .5ab 2 . 7  +  . 4 b
(11) (10) (10) (9)
b 17b17 0.9 + .4a 2.0 + .6b 2.1 + .4b 2.8 + .5b
(10) (9) (9) (9)
Control 3.5 + .2C 3.5 + , 2° 3.8 + .1° 3.9 + .1C
(11) (15) (10) (8)
abcMeans within columns or rows not followed by a common
letter are significantly different at P<0.05.
(n) = number of chicks
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TABLE 4. Mean body weight gain fa) of B genotypes 6 days 
following a 10.000 E. tenella oocvst challenge given 21 days 








R/R 54 + 4cd 59 + 8C 56 + 5C 51 + 7C
(9) (11) ' (ID (9)
17/R 53 + 9cd 51 + 7C 49 + 8C 47 + 10c
(11) (10) (10) (9)
17/17 61 + 5d 58 + 6cd 43 + 4bc 52 + 8C
(10) (9) (9) (9)
Control 5 + 8b 8 + 7b -28 + 10a -9 + llal
(11) (15) (10) (8)
abcMeans within columns or rows not followed by a common
letter are significantly different at P<0.05.
(n) = number of chicks
CHAPTER TWO
Immunogenicity of a Recombinant Eimeria tenella 




The immunogenicity of a recombinant Eimeria tenella 
coccidial antigen-5401 was studied in 61.B congenic chickens 
derived from B2b2 and B5B5 parents segregating for 
haplotypes B2 and B5. Five week old chickens were immunized 
with 2.4 ug of recombinant protein (designated 5401) and 
challenged with 75,000 oocysts 28 days post immunization 
(DPI) to determine the degree of elicited protective 
immunity. Serum samples were collected weekly for 5 weeks 
post immunization for ELISA, IFA and Western blot analysis.
Lesion scores following oocyst challenge were 
significantly reduced in B5I|5 chickens compared to B2B2 
chickens. Immunization induced a sporozoite-specific serum 
IgG titer detected by ELISA that peaked at 28 DPI, the day 
of challenge, in BSB5 chickens and at 42 DPI in B2B2 
chickens. Following challenge, this titer declined for each 
genotype. Anti-sporozoite IgG detected by IFA attained peak 
titer at 21 DPI in B2B2 chickens and 28 DPI in B5B5 
chickens. Serum from immunized B5B5 birds reacted strongly 
in Western blots with several high molecular weight soluble 
proteins (>100 kD) , prepared from sporozoites. Serum from 
B2B2 birds reacted with similar proteins as well as a 
51-53 kD protein not labeled by B^B^ serum. These results 
demonstrate further the role of host genetics on anti­
coccidial immunity, and suggest that a peak anti-sporozoite 




Coccidiosis is a parasitic intestinal disease affecting 
poultry and livestock worldwide. Infection with this 
obligate, intracellular protozoan causes a species-specific 
protective immune response at the expense of feed 
conversion, weight gain, and occasional mortality. Several 
studies have examined the role of host genetics in 
controlling both innate susceptibility to the disease (1-4) 
as well as acquired immunity (5,6). Specifically, the B5 
haplotype (7) of the chicken major histocompatibility 
complex (8) or B locus (9) has been implicated in conferring 
immunocompetence against Eimeria tenella (5) , the 
etiological agent of cecal coccidiosis in domestic fowl. In 
contrast, chicken hosts possessing the B2 haplotype were not 
protected against parasite challenge.
A recombinant £. tenella antigen cloned from the 
oocyst, the stage of this parasite ingested by its avian 
host, has been produced and characterized (10) . This 3 5 kD 
protein designated 5401 contains several amino acid repeat 
sequences, a trait also observed of the circumsporozoite 
antigen of Plasmodium falciparum. another Apicomplexan 
protozoan (11). Immunization of chickens with this antigen 
induced partial clinical protection to oral parasite 
challenge in a commercial outbred line of chickens (10) . 
The present study reports the differential humoral and 
associated clinical responses elicited by 5401 in congenic 
chickens segregating for haplotypes B2 and B5.
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Materials and Methods
Chickens. Inbred Single Comb White Leghorn (SCWL) line 
6-l (£2B2) , developed at the Regional Poultry Research
Laboratory (RPRL), East Lansing, MI, was selected as the 
background strain for the developing B congenic line. This 
line is histocompatible, resistant to Marek's disease, 
susceptible to subgroup A, B and C leukosis viruses, and 
regresses Rous sarcoma virus (RSV)-induced. tumors (12). 
Females of inbred SCWL line 15-^  (B5B5) , also developed at
RPRL, were crossed with line 6-^ to produce the F-^ 
generation. Line 15-^  is susceptible to Marek's disease and 
subgroup A leukosis virus, and progresses RSV-induced tumors
(13). For subsequent backcross generations, heterozygous 
B B females were mated to line 61 males. Eighth backcross 
generation heterozygous males and females were mated 
inter se to produce B2B2 or B^B^ homozygous progeny with 
>99% background gene uniformity (unpublished data).
A total of 55 chickens, divided among three trials, 
were used in this study. All progeny were typed for B 
alloantigens by hemagglutination (7). Chicks were raised 
coccidia-f ree to 5 weeks of age on wire floor brooding 
batteries and fed an non—medicated all-mash starter ad 
libitum.
Recombinant antigen and parasite. The recombinant 
coccidial antigen 5401, kindly provided by Genex 
Corporation, Gaithersburg, MD, was cloned from non- 
sporulated and sporulated oocysts of L.S. #24 strain
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E. tenella (Animal Parasitology Institute, Beltsville, MD), 
and produced in Escherichia coli (10) . The gene coding for 
this antigen was expressed in a lambda gtll bacteriophage 
vector, yielding a fusion protein of approximately 150 kD 
corresponding to about 35 kD coccidial antigen fused to 
Beta-galactosidase. Sequencing indicated that the antigen 
contained a primary structure of five repeating segments of 
nine amino acids each.
Immunization of chickens. Five week old chickens were 
immunized individually with 2.4 ug of antigen-5401 in 
saline, emulsified 1:1 in Freund's complete adjuvant (FCA), 
and injected in a 0.5 ml volume subcutaneously at the base 
of the neck. Previous titration studies showed a single dose 
of 2.4 ug was maximally protective (14). Unimmunized birds 
of each genotype were maintained as controls. Chickens were 
challenged at 2 8 days post immunization (DPI) by an oral 
inoculation of 75,000 L.S. #24 E. tenella oocysts (API) to 
determine the efficacy of antigen-5401 immunization.
Clinical criteria. Clinical disease was monitored 6 
days post oral inoculation by cecal lesion scores [scored 0 
to 4] (15) and body weight gain.
ELISA. Pooled serum samples within genotypes were 
taken weekly, beginning the day of immunization (Day 0) 
through day of termination (Day 42) to assess sporozoite- 
specific IgG titers. Control serum was obtained from 
chickens immunized with saline emulsified 1:1 in FCA. ELISA 
analysis was carried out essentially as previously described
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(16) . Briefly, sporozoites were excysted by standard 
procedures, passed over a scrubbed nylon wool column to 
remove debris, centrifuged, and resuspended in phosphate- 
buffered saline (PBS). Sporozoites were then disrupted with 
glass beads (100 um in diameter) by vortexing for 2 min. The 
material was centrifuged at 11,600 x g for 2 min and the 
supernatant fluid collected. A protein concentration was 
determined using the method outlined by Biorad (Biorad, 
Richmond, CA) . Soluble sporozoite antigen was then diluted 
in carbonate-bicarbonate buffer (pH 9.6) and adsorbed to 96 
well EIA plates (Costar, Cambridge, MA) at a concentration 
of 1 ug/well overnight at 4 C. All subsequent incubations 
were carried out at 41 C for 1 h. Plates were blocked with 
3% bovine serum albumen in PBS then rinsed three times with 
PBS-Tween 20. Serial dilutions of individual serum samples 
in PBS-Tween 20 were reacted with adsorbed antigen followed 
by three rinses in PBS-Tween 20. Plates were then exposed to 
a 1:1000 dilution of goat anti-chicken IgG horseradish 
peroxidase conjugate (Kirkegaard and Perry Laboratories, 
Inc., Gaithersburg, MD) in PBS. Plates were washed three 
times with PBS-Tween 20 and developed with tetramethyl 
benzidine (TMB) reagent (ICN Biomedicals, Costa Mesa, CA) . 
Absorbances were read on a microelisa reader (Dynatech, 
Alexandria, VA) at 450 nm and corrected for background. Mean 
absorbances from quadruplicate wells per trial are reported 
for 1/1600 serum dilutions.
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IFA. Sporozoites were obtained as described and fixed 
by air-drying to Toxoplasma titer slides at a concentration 
of 1 x 106/ml. Sporozoites were reacted with serial 
dilutions of immune sera and incubated at room temperature 
in a humid chamber for 1 h. Slides were washed for 10 min in 
PBS, then reacted with rabbit anti-chicken IgG (Kirkegaard 
and Perry Laboratories) diluted 1:30 in PBS and incubated 
for l h in humidity. Again slides were washed for 10 min in 
PBS, then reacted with fluorescein (FITC) conjugated goat 
anti-rabbit IgG (Kirkegaard and Perry Laboratories) diluted 
1:30 for 1 h in humidity. Slides were washed a final time in 
PBS, mounted with glycerol and observed under UV light 
microscopy.
PAGE and Western blot analysis. Approximately 2.0 X 107 
E. tenella sporozoites were disrupted with glass beads 
(100 um in diameter) by vortexing for 2 min in sample buffer
(17). The suspension was centrifuged at 11,600 x g for 
2 min, and the supernatant fluid was applied to a 10% SDS- 
polyacrylamide gel. The gel was electrophoresed at 3 5 mA for 
6 h. Separated sporozoite proteins were transferred from 10% 
SDS-gels onto nitrocellulose paper overnight at 30 V (18). 
The paper was blocked with 3% gelatin in Tris-buffered 
saline (TBS) for 2 h at 37 C, rinsed in water and exposed 
for 2 h at room temperature to 1:1000 dilutions of 5401- 
immunized chicken serum in antibody buffer. All subsequent 
incubations were for 2 h at room temperature. The paper was 
rinsed twice in PBS-Tween 2 0 and exposed to a 1:1000
47
dilution of rabbit anti-chicken IgG in antibody buffer. 
Following another two rinses in PBS-Tween, the paper was 
labeled with goat anti-rabbit horseradish peroxidase 
conjugate diluted 1:1000 in antibody buffer, then washed 
twice in PBS-Tween 20 and developed with 4-chloronaphthol 
reagent.
Statistics. All data were analyzed by analysis of 
variance, and means were tested using Student-Newman-Keul's 
(SNK) test at the 0.05 level of probability.
Results
Clinical response to parasite challenge. Oral challenge 
at 28 DPI induced moderately severe cecal lesions 6 days 
later at 34 DPI in 5401 immunized B2B2 chickens compared to 
essentially no infection in B5B5 chickens (Table I) . All 
unimmunized controls showed lesion scores of +4. Although 
immunized birds of each genotype gained more weight than 
unimmunized controls, this difference was not significant 
(P<0.05) (Table I).
Serum antibody oroduction-ELISA. A sporozoite-specific 
IgG titer was first detected by ELISA in B5B5 chickens at 
14 days post immunization (DPI) and continued to increase 
through 21 DPI with a peak at 28 DPI, the day of oral 
challenge (Fig. 1). In unchallenged B5B5 birds, the IgG 
titer fell sharply by 35 DPI and continued its decline to 
42 DPI. The IgG titer of challenged B5B5 chickens at 34 DPI, 
the day these birds were sacrificed for cecal lesion
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scoring, declined 50% (0.141) following challenge, but at a 
slower rate than unchallenged BSB5 birds. A sporozoite- 
specific IgG titer was barely detectable in B2B2 chickens at 
14 DPI but continued to rise slowly to a peak concentration 
at 42 DPI in unchallenged birds. Following oral challenge on 
28 DPI, the IgG titer of B2B2 chicks fell sharply at 34 DPI 
(day of lesion scoring) , to a level (0.082) approximately 
one-half of that measured in B5B5 chickens. No anti- 
sporozoite titers were measured in chickens of either 
genotype following immunization with saline and FCA (data 
not shown).
Serum antibody production-IFA. Immune sera from both 
genotypes produced a surface-internal immunof luorescent 
antibody pattern on air dried sporozoites, but each showed a 
different pattern of titer reactivity by IFA than ELISA. No 
IFA titers were detected at 7 DPI from birds of each 
genotype, while equivalent IFA titers were measured for each 
genotype at 14 DPI (Table II). In the absence of challenge, 
B2B2 sera peaked in anti-sporozoite titer at 21 DPI then 
declined from 28 to 35 DPI. In contrast, the B5B5 response 
which was lower than that of B2B2 peaked at 28 DPI and then 
declined. Following challenge at 28 DPI, however, B2B2 
titers were elevated to their highest levels on 3 5 DPI while 
B5B5 titers remained at their pre-challenge level.
Serum profiles to sporozoite antigen. Western blot 
analysis was used to characterize differential serum 
antibody reactivities following immunization with 54 01.
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Soluble sporozoite antigen was resolved on a 10% PAGE slab 
into several protein bands ranging in molecular weight 
between 15 and >200 kD (Fig. 2) . Upon Western transfer, 
serum from 5401-immunized B5B5 chickens consistently labeled 
several high molecular weight bands (>100 kD) beginning at 
14 DPI with strongest labeling or signal seen at 28 DPI 
(Fig. 2). A weaker signal was observed with serum from 
unchallenged B5B5 birds at 35 and 42 DPI. Serum from 5401- 
immunized B2B2 chickens labeled similar high molecular 
weight proteins although labeling was not detected until 
21 DPI. Unchallenged B2B2 serum gave the strongest signal at 
35 and 42 DPI. b 2B2 serum also reacted with a lower 
molecular weight band (approximately 51-53 kD) not labeled 
with b 5B5 serum. Serum from chickens of both genotypes 
immunized with saline and FCA did not react with Western 
blots (data not shown).
Discussion
The present study confirms the results of earlier 
clinical studies implicating the role of the chicken B (MHC) 
complex on immunity to coccidiosis (5,19). Chickens congenic 
for the B complex exhibited a differential response to a 
cloned coccidial protein following both immunization and 
parasite challenge. Immunization with recombinant antigen 
54 01 reduced cecal pathology following challenge in B5B^ 
birds while eliciting little protection in B2B2 hosts. Body 
weights were neither significantly influenced by parasite
50
challenge nor genotype, although immunized birds gained 
numerically more weight than unimmunized birds. This 
apparent uniformity in weight gain may reflect the highly 
inbred character of these lines.
Previous immunity studies using 5401 in a commercial 
outbred line demonstrated high IgG titers following 
immunization (9). In the present study anti-sporozoite IgG 
titers elicited by 5401, measured weekly by both ELISA and 
IFA, differed between both genotype and assays. ELISA and 
IFA exhibit inherently different antibody concentration 
sensitivities and specificities, and these patterns may 
explain the interassay differences in the titer profile. The 
ELISA technique used in this study would detect antibody 
specific for soluble sporozoite antigen only, while the IFA 
technique using air-dried sporozoites would measure antibody 
directed against antigens present in or on the intact 
parasites. There may be several antigens in common for each 
assay, and the different antigen preparations may select for 
or eliminate certain antigenic moieties. ELISA and IFA may 
measure an IgG titer to different antigens. In addition, the 
more sensitive ELISA may detect small quantities of antigens 
not detected by IFA. Both assays detected genotype 
differences in the magnitude and kinetics of the response. 
B5B5 chickens exhibited a peak IgG titer by ELISA at 2 8 
DPI, the day of the 75,000 oocyst challenge, and showed 
protection against that challenge 6 days later (34 DPI). On 
the other hand, B2B2 chickens produced a significantly lower
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IgG titer at 28 DPI, and were not protected against this 
same challenge dose. Six days following challenge (34 DPI), 
the B2B2 serum titer dropped to its lowest concentration. 
Therefore, a peak serum ELISA IgG titer at day of challenge 
was associated with a protective response to clinical 
disease in BSB5 chickens. Compared to the IgG titer in 
unchallenged birds, oral challenge in B5B5 chickens 
sustained an IgG titer, but challenge in B2B2 birds either 
suppressed the humoral response or bound circulating 
antibody. In contrast, a noninbred Light Sussex line showed 
a peak serum IgG titer 11-15 days following an oral 
inoculation of 10^ E. tenella oocysts and protection against 
subsequent parasite challenge (20), suggesting that the 
parasite elicited both a protective and more rapid response 
than the cloned antigen. However, this protection was at the 
expense of a severe clinical disease produced by the primary 
oocyst infection.
A different IgG titer profile was measured by IFA. The 
B2B2 serum IgG titer peaked 21 DPI and then declined in 
unchallenged birds. Following challenge, B2B2 serum titer 
increased to its highest level while the B5B5 IgG titer 
remained unchanged. An elevated IgG titer measured by IFA 
was not associated with protection to challenge in B2B2 
birds. These results may indicate the B2 haplotype is 
mediating a strong response to a non-protective antigen. A 
similar "decoy" scenario has been suggested in the response 
to the circumsporozoite antigen of malaria (21). Moreover,
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B2B2 birds respond most strongly to sporozoite antigen after 
challenge, a phenomenon which appears to abrogate a 
protective response.
Western blot analysis indicated a response similar to 
that measured by the ELISA, because the magnitude of 
antibody labeling or signal corresponded directly with 
measured titers; both assays utilized similar solid support 
antigens. Immune serum from both genotypes labeled similar 
high molecular weight protein bands. B2B2 serum collected 21 
and 28 DPI also labeled a 45 kd band not labeled by B5B5 
serum. Again, the B haplotype may be mediating a response 
against an antigen which either misdirects or inhibits 
protection.
Immunity to the avian eimeria has been shown to be a 
T cell-mediated response (22). Previously, there were little 
data supporting a direct humoral role in the protective 
response to coccidiosis, although immunity to E. tenella may 
be augmented by secretory IgA (23,24). The present data 
clearly demonstrate the association between a peak serum 
anti-sporozoite IgG titer on day of parasite challenge and 
reduced cecal pathology following immunization with a 
recombinant antigen.
In addition, the B5 haplotype appears to impart a
greater efficiency in mounting the IgG response than does
2 *B . Although parasite neutralization may ultimately involve
T cells, the efficiency of the response may be inherent in
antigen presentation as a result of the interaction between
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parasite antigen and MHC gene products on antigen presenting 
cells (APC) (25) . In this system, antigen-5401 may have a 
stronger affinity for the class II molecule encoded by the 
B5 haplotype than the corresponding molecule encoded by the 
B2 haplotype. Thus, JJ5B5 chickens may be considered high 
responders to antigen-5401 and B2B2 chickens low responders. 
Similar genetic responsiveness was described in mice 
immunized with a P. falciparum sporozoite vaccine and shown 
to map to the I-A region of the murine MHC (26).
The initial response to antigen-5401, a soluble 
antigen, may be B cell mediated, as the B cell may serve as 
the APC along with an obligatory production of parasite- 
specific IgG and subsequent secretory IgA (27) . It is not 
known what direct role these antibodies may have, if any, in 
arresting parasite development. Antigen presentation during 
a natural infection may involve macrophages (28) or 
intraepithelial lymphocytes (29) . Therefore, the use of a 
recombinant antigen such as antigen-5401 may invoke an 
additional cellular component, B cells, which may serve in 
some capacity to neutralize parasitism.
These results demonstrate the role of host genetics in 
ascertaining the efficacy of a recombinant protein as a 
vaccine. The use of these congenic lines of chickens 
indicate that a high anti-sporozoite IgG titer at the time 
of challenge is associated with protection elicited by the 
genetically-engineered antigen. The ability of a recombinant
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coccidial protein to stimulate a IgG response may indicate 
an effective vaccine component.
55
Literature Cited
1. Martin, A., W.B. Gross, E.A. Dunnington, R.W. Briles,
W.E. Briles, and P.B. Siegal. 1986. Resistance to
natural and controlled exposures to Eimeria tenella: 
Genetic variation and alloantigenic systems. Poultry 
Sci. 65:1847.
2. Johnson, L.W. and S.A. Edgar. 1986. Ea-B and Ea-C
cellular antigen genes in Leghorn lines resistant and 
susceptible to acute caecal coccidiosis. Poultry Sci. 
65:241.
3. Johnson, L.W. and S.A. Edgar. 1984. Ea-A and Ea-E
cellular antigen genes in Leghorn lines resistant and 
susceptible to acute cecal coccidiosis. Poultry Sci. 
63:1695.
4. Mathis, G.F., K.W. Washburn, and L.R. McDougald. 1984.
Genetic resistance to Eimeria acervulina, and E. 
tenella in chickens. Theor. Appl. Genet. 68:385.
5. Clare, R.A., R.G. Strout, R.L. Taylor, Jr., W.M.
Collins, and W.E. Briles. 1985. Major
histocompatibility (B) complex effects on acquired 
immunity to cecal coccidiosis. Immunogenetics 22:593.
6. Lillehoj, H.S., P.C. Allen, M.D. Ruff. 1985. Comparative
studies of humoral and cellular immune responses in two 
inbred strains of chickens showing different 
susceptibility to coccidiosis. In: Research in avian
coccidiosis. L.R. McDougald, L.R. Joyner, P.L. Long, 
eds. Univ. of Georgia, Athens, GA. pp.470-481.
7. Briles, W.E. and R.W. Briles. 1982. Identification of
haplotypes of the chicken major histocompatibility 
complex (B). Immunogenetics 15:449.
8. L.W. Schierman and A.W. Nordskog. 1961. Relationship of
blood type to histocompatibility in chickens. Science 
134:1008.
9. Briles, W.E., W.H. McGibbon, and M.R. Irwin. 1950. On
multiple alleles affecting cellular antigens in the 
chicken. Genetics 35:633.
10. Danforth, H.D. and P.C. Augustine. 1986. Use of 
hybridoma antibodies and recombinant DNA technology in 
protozoan vaccine development. Avian Dis. 30:37.
56
11. Dame, J.B., J.L. Williams. T.F. McCutchan, J.L. Weber,
R.A. Wirtz, W.T. Hockemeyer, W.L. Maloy, J.D. Haynes, 
I. Schneider, D. Roberts, G.S. Sanders, E.P. Reddy, 
C.L. Diggs, and L.H. Miller. 1984. Structure of the 
gene encoding the immunodominant surface antigen on the 
sporozoite of the human malaria parasite Plasmodium
falciparum. Science 225:593.
12. Shen, P.F., E.J. Smith, and L.D. Bacon. 1984. The
ontogeny of blood cells, complement, and 
immunoglobulins in 3- to 12-week-old 15I5-B congenic
White Leghorn chickens. Poultry Sci. 63:1083.
13. Collins, W.M., W.E. Briles, R.M. Zsigray, W.R. Dunlop,
A.C. Corbett, K.K. Clark, J.L. Marks, and T.P. McGrail. 
1977. The B locus (MHC) in the chicken: Association
with fate of RSV-induced tumors. Immunogenetics 5:333.
14. Danforth, H.D. and P.C. Augustine. 1988. Coccidia
vaccines. In: Veterinary protozoan and hemoparasite
vaccines. I.G. Wright, ed. CRC Press, Boca Raton, 
Florida.
15. Johnson, J and W.M. Reid. 1970. Anticoccidial drugs:
Lesion scoring techniques in battery and floor pen 
experiments with chickens. Exp. Parasitol. 28:30.
16. Rose, M.E. and P.A. Mockett. 1983. Antibodies to
coccidia: Detection by the enzyme-linked immunosorbent 
assay (ELISA). Parasite Immunol. 5:479.
17. Laemmli, U.K. 1970. Cleavage of structural proteins
during the assembly of the head of bacteriophage T.. 
Nature 227:680.
18. Tsang, V.C.W., J.M. Peralta, and R.A. Simons. 1983.
Enzyme-linked immunoelectrotransfer blot techniques 
(EITB) for studying the specificities of antigens and 
antibodies separated by gel electrophoresis. Methods 
Enzymol. 92:377.
19. Ruff, M.D. and L.D. Bacon. 1984. Coccidiosis in 15.B
congenic chicks. Poultry Sci. 63(Suppl. 1):172-173.
20. Mockett, A.P.A. and M.E. Rose. 1986. Immune responses to
eimeria: quantification of antibody isotypes to Eimeria 
tenella in chicken serum and bile by means of the 
ELISA. Parasite Immunol. 8:481.
21. Mitchell, G.F. 1987. Injection versus infection: The
cellular immunology of parasitism. Parasitol. Today 
3:106.
57
22. Klesius, P.H. and J.J. Giambrone. 1984. Adoptive
transfer of delayed hypersensitivity and protective 
immunity to Eimeria tenella with chicken derived 
transfer factor. Poult. Sci. 63:13 33.
23. Clare, R.A. , R.G. Strout, R.L. Taylor, Jr. and P.A.
Aeed. 1987. Bile and serum immunoglobulin levels during 
primary and secondary infections with Eimeria tenella 
in chickens. Vet. Parasitol. 25:33.
24. Davis, P.J. and P. Porter. 1979. A mechanism for
secretory IgA-mediated inhibition of the cell 
penetration and intracellular development of Eimeria 
tenella. Immunology 36:471.
25. Schwartz, R.H. 1985. T-lymphocyte recognition in
association with gene products of the major 
histocompatibility complex. Ann. Rev. Immunol. 3:237.
26. Good, M.H., J . A. Berzofsky, W.L. Maloy, Y. Hayashi, N.
Fujii, W.T. Hockmeyer, and L.H. Miller. 1986. Genetic 
control of the immune response in mice to a Plasmodium 
falciparum sporozoite vaccine. Widespread
nonresponsiveness to single malaria T epitope in highly 
repetitive vaccine. J. Exp. Med. 164:655.
27. Chestnut, R.W. and H.M. Grey. 1985. Antigen
presentation. CRC Crit. Rev. Immunol. 5:263.
28. Rose, M.E. 1974. Immune responses in infections with
coccidia: Macrophage activity. Infect. Immun. 10:862.
29. Lawn, A.M. and M.E. Rose. 1982. Mucosal transport of
Eimeria tenella in the cecum of the chicken. J. 
Parasitol. 68:1117.
58
Table I* Mean cecal lesion scores and body weight gain (g) 
6 days following oral E. tenella oocyst challenge (28 DPI) 
of 6-^ .B congenic chickens previously immunized with 
recombinant E. tenella antigen-5401.




B2/B2-immune 10 3. 2b 99.5+17.3 g
B5/B5-immune 9 <la 86.7+14.6 g
Control-infected 10 4 . 0b 66.1+ 3.7 g
a '^ Means not 
P<0.05.
followed by a common letter are significant at
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Table II. Anti-sporozoite serum IgG titers, detected by IFA 
and reported as reciprocal dilutions, from 6^15 congenic 
chickens immunized with recombinant E, tenella antigen-5401 
on day 0 and challenged with 75,000 E. tenella oocysts 
28 DPI.
B Genotype 0 7
Day
14 21 28 35 34C*
B2/B2 0 0 80 320 160 40 500
B5/B5 0 0 80 160 160 80 160
*Serum IgG titers of birds challenged at 28 DPI and scored
for cecal lesions at 34 DPI.
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Figure 1- Anti-sporozoite serum IgG titers, detected by 
ELISA and reported as Abs.450, of S-^ .B congenic chickens 
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Figure 2. Western blot analysis of serum from B5B5 or B2B2 
birds immunized with antigen-5401 on E. tenella sporozoite 
preparation. Lanes 1 and 7 at 7 DPI, lanes 2 and 8 at 
14 DPI, lane 3 and 9 at 21 DPI, lanes 4 and 10 at 28 DPI,
lanes 5 and 11 at 35 DPI, and lanes 6 and 12 at 42 DPI.
Asterisks in lanes 9-12 placed beside 51-53 kD antigen
reacting with serum from B2B2 immunized birds. Positions of 
Mr markers are identified on left of figure, and from top to 
bottom correspond to myosin, 200 kD; phosphorylase B, 97 kD; 
serum albumen, 68 kD; ovalbumen, 4 3 kD; and alpha-
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CHAPTER THREE
Major Histocompatibility Complex Control 
of Immunity Elicited By Genetically Engineered 




Immunity elicited by a recombinant coccidial antigen 
#3264 was studied in 6-j^ .B congenic chickens segregating for 
haplotypes B2 and B5. Antigen 3264, cloned from Eimeria 
tenella oocysts, was administered in Freund's complete 
adjuvant to 5 week old chickens in doses of either 2.4 ug, 
10 ug, or 20 ug. Immunized chicks were then given a boost 
dose of 10 ug, 10 ug, or 20 ug, respectively. Seven days 
following the boost all chicks were exposed to 25,000 
oocysts. Body weight gain and cecal lesion scores in 
response to parasite challenge were measured. Serum was 
collected weekly for ELISA and western blot analysis. 
Peripheral lymphocytes were also collected weekly for an in 
vitro proliferation assay.
In all three immunization protocols, 3264 elicited a 
protective response only in B5B5 chickens. B2B2 and B5B5 
chickens responded differently in serum igG titer and in the 
magnitude of lymphocyte proliferation. Western blot analysis 
showed differential labeling of certain low molecular weight 
proteins. Together, these findings demonstrate how genetic 
responsiveness linked to the major histocompatibility 




Eimeria tenella. an obligate intracellular protozoan 
parasite, is the etiologic agent of cecal coccidiosis in 
domestic chickens. Avian coccidia (Family Eimeriidae) belong 
to the Phylum Apicomplexa, as do the Plasmodia (Family 
Plasmodiidae). and both share similar development patterns. 
To date, both genera are the subject of intense vaccine 
research (7,16), with considerable emphasis being placed 
upon the ability to clone reactive sporozoite surface 
antigens (6,20). The sporozoite is the first parasitic stage 
to penetrate host cells and would be a likely candidate to 
trigger the host/s immune system.
Recent studies have examined the host's response to 
candidate malarial antigens at the level of the major 
histocompatibilty complex in mice (8,9). These studies 
demonstrated that high and low responders occurred in a 
given mouse population, and that these responses were MHC 
restricted. Similarly, avian host immune responses to 
coccidiosis have been shown to be MHC-1inked (3,11,13, 
Clare, unpublished) .
A candidate coccidial antigen, designated 3 2 64, has 
been successfully cloned from sporulated oocysts of E. 
tenella (Danforth and Augustine, unpublished). The response 
to 3264 in vivo elicits partial protection in a commercially 
available strain of chickens (Danforth and Augustine, 
unpublished). It is quite possible that the host variation 
which leads to this incomplete protection is derived, in
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part, from MHC effects. The purpose of the present study is 
to evaluate the response to the 32 64 antigen in chicken 
hosts congenic for the MHC using different antigen dose 
levels. These studies may provide an additional insight into 
the interaction between host and potential protozoan
vaccines.
Materials and Methods 
Chicken hosts. Five week old line 6-j^ .B partially
congenic chicks segregating at the B locus for alleles B2 
and B5 were used in this study. Inbred Single Comb White 
Leghorn (SCWL) line 6-j^ (B2B2) , developed at the Regional
Poultry Research Laboratory (RPRL) , East Lansing, MI, was 
selected as the background strain for the developing B 
congenic line. Females of inbred SCWL line 15-^  (B5B5) , also
developed at RPRL, were crossed with line 6^ to produce the 
generation. Subsequent backcross generations were derived 
from heterozygous B2B5 females mated to line 61 males. Line 
6^ is histocompatible, resistant to Marek's disease,
susceptible to subgroup A, B and C leukosis viruses, and 
regresses Rous sarcoma virus (RSV)-induced tumors (18), 
while line 15^ is susceptible to Marek's disease and 
subgroup A leukosis virus, and progresses RSV-induced tumors 
(4) . Eighth backcross generation heterozygous males and 
females were mated inter se to produce B2B2 or BSB5
homozygous progeny with >99% background gene uniformity 
(unpublished data) .
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Chicks were typed at 2 weeks of age for B alloantigens 
by hemagglutination (2) . All chicks were housed in wire- 
floored cages and provided unmedicated feed and water ad 
libitum.
Antigen and parasites. The genetically engineered antigen 
used in this study, designated 3264, was cloned from 
sporulated oocysts of E. tenella {L.S. #24 strain, Animal
Parasitology Institute, Beltsville, MD). The gene coding for 
this antigen was expressed in a lambda gtll bacteriophage 
vector which yielded a fusion protein of approximately 
150 kD corresponding to about 3 5 kD coccidial antigen fused 
to Beta-galactosidase (Danforth and Augustine, unpublished). 
An oral inoculum of 2 5,000 sporulated L.S. #24 E. tenella 
oocysts was used as a parasite challenge to test the 
immunogenicity of the cloned antigen.
Immunization studies. Three experiments using different 
immunization protocols were completed. In all studies, 
antigen-3264 emulsified in Freund's complete adjuvant was 
injected subcutaneously at the base of the neck into 5 week 
old 6-j^ .B congenic chicks. In Experiment 1, birds were 
immunized on Day 0 with 2.4 ug of antigen-3 2 64 and received 
a booster injection of 10 ug antigen-3264 at Day 28. Seven 
days following the booster injection, chicks were challenged 
with 3 0,000 oocysts. In Experiment 2, birds were immunized 
with 10 ug 3264 on Day 0, boosted with 10 ug 3264 on Day 21, 
and exposed to oocysts on Day 28. In Experiment 3, birds 
were immunized with 20 ug 32 64 on Day 0, boosted with 20 ug
69
3264 on Day 14, and exposed to oocysts on Day 21. In all 
experiments, age-matched birds not receiving antigen 
treatment were maintained as controls for the challenge 
exposure.
Clinical disease. Body weight gain was measured during 
the 6 day prepatent period immediately following parasite 
challenge, afterwhich immunized and non-immunized control 
birds were killed and cecal lesion scores determined (10) .
ELISA. Serum samples pooled within genotypes were taken 
weekly, beginning the day of immunization (Day 0) through 
the sixth day following oocyst challenge to assess 
sporozoite-specific IgG titers. Control serum was obtained 
from chickens immunized with saline emulsified 1:1 in FCA.
Serum antibody titer analysis was carried out using a 
modification of the procedure reported by Rose and Mockett
(14). Sporozoites were excysted aseptically by standard 
procedures, passed over a scrubbed nylon wool column to 
remove debris, centrifuged, and resuspended in phosphate- 
buffered saline (PBS). Sporozoites were then disrupted with 
glass beads (100 um in diameter) by vortexing for 2 min. The 
material was centrifuged at 11,600 x g for 2 min and the 
supernatant fluid collected. The protein concentration was 
determined using the method outlined by Biorad (Biorad, 
Richmond, CA) . Soluble sporozoite antigen was then diluted 
in carbonate-bicarbonate buffer (pH 9.6) and adsorbed to 96 
well EIA plates (Costar, Cambridge, MA) at a concentration 
of 1 ug/well overnight at 4 C. All subsequent incubations
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were carried out at 41 C for 1 h. Plates were blocked with 
3% bovine serum albumen in PBS, then rinsed three times with 
PBS-Tween 20. Serial dilutions of pooled serum samples in 
PBS-Tween 2 0 were reacted with adsorbed antigen followed by 
three rinses in PBS-Tween 20. Plates were then exposed to a 
1:1000 dilution of goat anti-chicken IgG horseradish 
peroxidase conjugate (Kirkegaard and Perry Laboratories, 
Inc. , Gaithersburg, MD) in PBS. Plates were washed three 
times with PBS-Tween 2 0 and developed with tetramethyl 
benzidine (TMB) reagent (ICN Biomedicals, Costa Mesa, CA) . 
Absorbances were read on a microelisa reader (Dynatech, 
Alexandria, VA) at 450 nm and corrected for background. Mean 
absorbances from quadruplicate wells per trial are reported 
for 1/1600 serum dilutions.
PAGE and Western blot analysis. Approximately 2.0 X 107 
E. tenella sporozoites were disrupted with glass beads 
(100 um in diameter) by vortexing for 2 min in sample buffer 
(12). The suspension was centrifuged at 11,600 x g for 
2 min, and the supernatant fluid was applied to a 10% SDS- 
polyacrylamide gel. The gel was electrophoresed at 35 mA for 
6 h. Separated sporozoite proteins were transferred from 10% 
SDS-gels onto nitrocellulose paper overnight at 30 V (19) . 
The paper was blocked with 3% gelatin in Tris-buffered 
saline (TBS) for 2 h at 37 C, rinsed in water and exposed 
for 2 h at room temperature to 1:500 dilutions of 3264- 
immunized chicken serum in antibody buffer. All subsequent 
incubations were for 2 h at room temperature. The paper was
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rinsed twice in PBS-Tween 20 and exposed to a 1:1000 
dilution of rabbit anti-chicken IgG in antibody buffer. 
Following another two rinses in PBS-Tween, the paper was 
labeled with goat anti-rabbit horseradish peroxidase 
conjugate diluted 1:1000 in antibody buffer, then washed 
twice in PBS-Tween 2 0 and developed with 4-chloronaphthol 
reagent.
Lymphocyte proliferation assay. Blood from sensitized 
birds was collected weekly and assayed for the degree of in 
vitro lymphocyte stimulation by soluble sporozoite antigen 
(1) . A lymphocyte-enriched culture was prepared using a 
colloidal silica suspension (Sepratech, Oklahoma City, OK). 
Mononuclear cells were suspended in RPMI 1640 medium, 
containing ITS [insulin/transferrin/selinium] (Collaborative 
Research, Cambridge, MA) and 5% fetal bovine serum, at a 
concentration of 5 x 106 viable cells/ml. Microcultures were 
established in tissue culture microtitre plates (Costar, 
Cambridge, MA) by the addition of 100 ul (5 x 105 cells) of 
cell suspension. The three treatments, each repeated six 
times, were as follows: 1) 1 ug/well of soluble sporozoite
antigen in 100 ul of medium; 2) 25 ug/well of 
phytohemagglutinin (PHA) in 100 ul of medium; 3) 100 ul/well 
of control media. Cultures were incubated for 72 h at 41 C 
in 5% C02 - Mitogenic responses were assayed by the addition 
of 0.5 uCi 3H-[methyl]-thymidine (3H-TdR) (6.7 Ci/mmole; New 
England Nuclear, Boston, MA) in 25 ul medium 18 h prior to 
harvesting. Cells were harvested on to glass fiber filters
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using an automated cell harvester. Dried filter discs were 
prepared in toluene-PPO and counted in a Beckman liquid 
scintillation counter. Results are expressed as a
stimulation index (SI) as follows:
SI = avg. cpm antigen or PHA/avg. cpm control.
Statistics. All data were analyzed by analysis of 
variance to test genotype and treatment as main effects. 
Means were separated using Student-Newman-Keul's (SNK) test 
at the 0.05 level of probability.
Results
Effect of B genotype and immunization on clinical
disease. Preliminary studies revealed that 32 64 did not 
elicit a protective response to challenge when administered 
in a single primary injection in the 6-j^ B congenic
segregants (data not shown). Thus, three different 
immunization regimens, consisting of a primary injection and 
a secondary boost, were used to assess protection to 
parasite challenge elicited by 3264. In all three
experiments, immunized homozygous B5B5 chicks showed 
protection in terms of significantly lower cecal lesion 
scores than similarly immunized homozygous B2B2 chicks 
(Table 1) . In addition, B5B5 chicks gained significantly
more weight following challenge than B2B2 chicks in
Experiments 2 and 3.
Anti-soorozoite antibodies elicited bv 3264. In
Experiment i (Fig. 1), birds of both genotypes, primed with
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2.4 ug and boosted with 10 ug on Day 28, exhibited a similar
serum IgG titer response with titers peaking on Day 14,
declining to Day 28, then increasing following the 10 ug 
boost to Day 35. At Day 35, B5B5 serum had a significantly 
higher titer than B2B2 serum.
In contrast, B5B5 serum showed a significantly higher 
titer at Days 14 and 21 than B2b2 serum following a primary 
injection of 10 ug 3264 in Experiment 2 (Fig. 2). Following 
the 10 Ug boost on Day 21, IgG titer in B5B5 chicks declined
while IgG levels remained essentially the same in B2B2
chicks.
When the primary and secondary antigen doses were 
increased to 20 ug each on Days 0 and 14, respectively in
Experiment 3, B2B2 serum IgG titer appeared on Day 14, was
essentially unaffected by the booster injection, but 
increased markedly following challenge, to a titer 
significantly greater than that of B5B5 birds (Fig. 3). B5B5 
titer was significantly higher than B2B2 titer on Day 21 
following the Day 14 boost, but its titer declined following 
challenge.
Western blot analysis of 3264 elicited antibody. Western 
analysis of serum samples permitted a characterization of 
different Ag-Ab specificities induced by 3264 immunization. 
Soluble sporozoite antigen was resolved on a 10% PAGE slab 
into several protein bands ranging in molecular weight from 
15 to > 200 kD. In Experiment 2 (Fig. 4) , B2B2 serum
collected on Days 14, 21, and 28 labeled several protein
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bands in excess of 68 kD, with the most intense signal given 
at Day 28, seven days following the 10 ug boost. In 
addition, B2B2 serum collected on Day 14 labeled a low 
molecular weight band, approximately 15-18 kD, not labeled 
on Days 21 and 28, and never labeled by B5B5 serum. b5B5 
serum labeled similar protein bands >68 kD; however, a very 
weak signal was detected on Day 14 that intensified on Days 
21 and 28, but not to the magnitude of the B2B2 signal. In 
contrast, only B5B5 serum collected on Day 28 labeled two 
bands of approximately 51-53 kD and 58-60 kD, respectively.
Similar protein bands >68 kD were labeled with serum of 
both genotypes collected in Experiment 3 (Fig. 5) . The B2B2 
signal was weak on Days 14 and 21, and was completely absent 
7 days following the challenge at Day 28. The B5B5 signal 
was strongest on Day 14 and weakened progressively on Days 
21 and 28. However, B5B5 serum collected on Day 28, 7 days
following challenge, again labeled a low molecular weight 
band, approximately 51-53 kD, not labeled by B2B2 serum.
3 2 64 induced lvmphoproliferation. Peripheral lymphocytes 
were collected from birds of both genotypes in Experiment 2 
on Days 0, 14 and 21 and were subjected to in vitro
stimulation with soluble sporozoite antigen (Fig. 6) . 
Lymphocytes collected prior to 32 64 injection responded 
minimally for each genotype. Fourteen days following 
sensitization, B5B5 lymphocytes showed a significantly 
greater proliferative response to sporozoite antigen than 
B2B2 lymphocytes. By Day 21, however, this B5B5
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proliferative response had returned to the level measured in 
unsensitized (Day 0) lymphocytes. PHA stimulated lymphocytes 
from birds of both genotypes responded essentially to the 
same magnitude with proliferation indices of 35 for B2B2 
cells and 39 for B5b5 cells (not shown).
Discussion
In this study, we investigated the immunogenicity of 
recombinant E. tenella protein 3264 and its ability to 
elicit a protective response in 6-^ .B congenic chickens 
segregating for alleles B2 and B5. Previous studies have 
shown injected antigen extracts prepared from lysed oocysts 
or sporozoites of E. tenella. to effectively elicit 
protective immunity against parasite challenge in chickens
(15). Recombinant forms of similar antigens induced only 
partial protection to challenge (6). Although recombinant 
antigens may be produced efficiently in large quantities, 
this technique may inherently alter protein conformation and 
limit the number of epitopes expressed to the host. This 
consequence could affect the response pattern of certain 
associated MHC alleles.
In all cases, chickens homozygous for the B5 allele 
showed significantly greater protection to parasite 
challenge following immunization than B2B2 homozygotes. 
These results support previous studies (3,11,13) 
demonstrating that the B complex plays a profound role in 
the host response to cecal coccidiosis. Studies by Clare and
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coworkers (3) first reported that the B5 allele was 
associated with a greater protective immune response to E. 
tenella parasitism than the B2 allele. Ruff and Bacon (17) 
suggested that expression of the B5 allele may also be 
associated with innate resistance to parasitism. In 
addition, work in this laboratory, using similar congenic 
chickens, established the identical response pattern of 
these B alleles to another recombinant E. tenella antigen, 
5401 (Clare, unpublished).
Both 3264 and 5401 are derived from the same cloned 
gene, coding for a protein molecule consisting of several 
repeats of a nine amino acid sequence, but are expressed in 
different plasmids (Danforth and Augustine, unpublished). 
The use of different plasmids changes the number of total 
repeats which appear in the final fusion protein. Although 
both 3264 and 5401 have a molecular weight of approximately 
35 KD, 3264 appears to be expressed missing at least one 
repeat sequence.
A single dose of 2.4 ug 5401 elicited a protective 
response in B5B5 chickens (Clare, unpublished) and partial 
protection in a commercial strain (6) . This same dose of 
32 64 was not sufficient to establish immunity to challenge 
in the B congenics. In fact, a primary injection of 3264 had
to be combined with a secondary booster to obtain protection
5 5in B B chickens* The difference in plasmid expression 
between 3264 and 5401 appears to alter the immunogenicity of 
these proteins.
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The serum IgG response to 3264 detected by ELISA was 
influenced by the dose of antigen administered. Following
2.4 ug of 3264 in Experiment l, birds of both genotypes 
responded essentially to the same magnitude. Increasing the 
primary dose to 10 ug in Experiment 2 appeared to suppress 
the B2b2 response at Day 14, while stimulating a marked 
increased titer in B5B5 birds at Day 21. The 2 0 ug dose 
given in Experiment 3 appeared to suppress IgG titers in 
birds of both genotypes at Days 14 and 21. Following the 
25,000 oocyst challenge on Day 21, the B2B2 titer increased 
approximately two-fold at Day 28. What these anti-sporozoite 
IgG titers mean in terms of the immune status of the chicken 
is not clear. In previous studies with antigen 5401 a peak 
titer in B5B5 birds on the day of challenge was associated 
with protection {Clare, unpublished). This observation may 
be the case with Experiments 1 and 3 of the present study, 
but not in Experiment 2 where titers of both genotypes were 
essentially the same on the day of challenge.
Western analysis showed that birds of both genotypes 
respond to similar sporozoite proteins >68 kD, although the 
magnitude of antibody labeling changes with time following 
immunization. The large number of protein bands labeled 
indicates that epitopes associated with 32 64 are expressed 
on several different sporozoite proteins, or that these 
bands represent subunits of a larger protein resulting from 
soluble antigen preparation. In contrast, B5B5 serum 
consistently labeled one or two low molecular weight bands
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on Days 21 and 28, never labeled by serum. Recognition
of these bands may be MHC-restricted and ultimately 
associated with protection.
Results from the lymphocyte stimulation study supported 
further an increased level of immunocompetence among B5B5 
chickens immunized with 3264. A significant increase in 
stimulation was observed in B5B5 chickens over B2B2 chickens 
at Day 14 in Experiment 2, but returned to control levels at 
Day 21. The Day 14 response may be signaling a period of 
peak immune activity.
The exact nature of this MHC mediated response requires 
further analysis. Similar responsiveness has been described 
in mice immunized with a candidate malaria vaccine (8,9). 
Our results conclude that the efficacy of a recombinant 
coccidial vaccine may be limited by its degree of 
interaction with a given MHC genotype.
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TABLE 1. Effect of immunization with antigen-3264 on a 










1 2/2 7 2.4/10 3.2 + .3 71 + 11 g
1 5/5 10 2.4/10 2.4 + .2 63 + 5 g
2 2/2 7 10/10 3.4 ± •3 59 + 8 g
2 5/5 11 10/10 1.6 + .3 77 + 3 g
3 2/2 11 20/20 3.0 + .2 56 + 8 g





I1I + .2 77 ± 5 g
aPrimary/boost (ug) injections of Ag-3264 given on the 
following days, respectively: Expt. 1-Day 0/Day 28; Expt. 
2-Day 0/Day 21; Expt. 3-Day 0/Day 14. All challenge 
exposures were given 7 days following the boost 
injection.
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Figure 1. Experiment 1. Anti-sporozoite serum IgG titers, 
detected by ELISA at a 1/800 dilution and reported as 
Abs.450, of 6-j^ .B congenic chickens immunized with 2.4 ug 
recombinant E. tenella antigen 3264 on Day 0 and boosted 


























Figure 2. Experiment 2. Anti-sporozoite serum IgG titers, 
detected by ELISA at a 1/800 dilution and reported as 
Abs.45Q, of 6-^ .B congenic chickens immunized with 10 ug 
recombinant E. tenella antigen 3264 on Day 0 and boosted 
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Figure 3. Experiment 3. Anti-sporozoite serum IgG titers, 
detected by ELISA at a 1/800 dilution and reported as 
Abs.450, of 6-j^ .B congenic chickens immunized with 20 ug 
recombinant E. tenella antigen 3 264 on Day 0 and boosted 
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Figure 4. Experiment 2. Western blot analysis of serum from 
6-^ .B congenic chickens immunized with recombinant E. tenella 
antigen 3264 on E. tenella sporozoite preparation. Lanes 1 
and 2 at Day 14, lanes 3 and 4 at Day 21, and lanes 5 and 6 
at Day 28. B2B2 serum is reacted in lanes 1, 3, and 5; B5B5 
serum is reacted in lanes 2,4, and 6. Asterisk in lane 1 
placed beside 15-18 kD antigen reacting with serum from B2B2 
birds. Asterisks in lane 6 placed beside 51-53 kD and 58- 
60 kD antigens reacting with serum from B5B5 birds. 
Positions of Mr markers are identified on left of figure, 
and from top to bottom correspond to myosin, 2 00 kD; 
phosphorylase B, 97 kD; serum albumen, 68 kD; ovalbumen, 
4 3 kD; alpha-chymotrypsinogen, 2 5 kD, beta-lactoglobulin, 






Figure 5. Experiment 3. Western blot analysis of serum from 
6-^ .B congenic chickens immunized with recombinant E. tenella 
antigen 3264 on E. tenella sporozoite preparation. Lanes 1 
and 2 at Day 14, lanes 3 and 4 at Day 21, and lanes 5 and 6 
at Day 28. B2B2 serum is reacted in lanes 1, 3, and 5; B^B5 
serum is reacted in lanes 2,4, and 6. Asterisk in lane 6 
placed beside 51-53 kD antigen reacting with serum from B5B5 
birds. Positions of Mr markers are identified on left of 
figure, and from top to bottom correspond to myosin, 200 kD; 
phosphorylase B, 97 kD; serum albumen, 68 kD; ovalbumen, 
43 kD; alpha-chymotrypsinogen, 25 kD, beta-lactoglobulin, 








Figure 6. Experiment 2. Lymphocyte proliferation indices of 
peripheral lymphocytes collected from 6^ • Bj congenic chickens 
immunized with 10 ug recombinant E. tenella antigen 32 64, 























Comparative Analysis of Eimeria tenella Sporozoite and 
Merozoite Surface Antigens Labeled by Serum Antibodies 




Antisera were raised in 5 week old 6 ^ • B congenic 
chickens against a recombinant coccidial protein, designated 
3264, which has been shown previously to elicit a protective 
immune response to Eimeria tenella. Serum was collected 
weekly for 4 weeks following subcutaneous immunization with 
3264 emulsified in Freund's complete adjuvant. Specific 
antibodies were used to label air-dried E. tenella 
sporozoites and merozoites in an indirect fluorescent 
antibody (IFA) assay.
Antibodies raised against 3264 strongly labeled only 
the anterior portion of the sporozoite. In contrast, these 
same antibodies strongly labeled only the posterior portion 
of second generation merozoites. First generation merozoites 
were only slightly labeled, if at all. In addition, a single 
heavily labeled nodule, possibly an immune complex, was 




The protozoan diseases human malaria and avian 
coccidiosis are the subject of intense research toward the 
production of recombinant vaccines (Young et al, 198 5; 
Danforth and Augustine, 1988) . For both obligate 
intracellular protozoan parasites, cloned sporozoite 
antigens are being evaluated for their ability to elicit a 
protective immune response (Nussenzweig and Nussenzweig, 
1984; Danforth, 1985). Several sporozoite surface antigens 
have been identified and characterized from the coccidium 
Eimeria tenella (McAndrew et al. , 1986; Truitt et al. ,
1986) . Two candidate proteins have been described which 
induce partial protection to parasite challenge in avian 
hosts (Danforth and Augustine, 1985; Danforth and Augustine, 
unpublished). Each protein elicits antibodies which react 
with surface and internal structures of sporozoites in an 
indirect fluorescent assay as well as several high molecular 
weight sporozoite proteins in a western blot analysis. The 
reactivities of these antibodies to merozoites or merozoite 
antigen has not been described. The purpose of the present 
study is to compare the different surface antigens of 
sporozoites and merozoites of E. tenella using antibodies 
raised against a recombinant coccidial protein. In addition 
this work may permit a further understanding of the 




Five week old 6 -^ .B congenic chickens were used in this 
study. All chicks were housed coccidia-free in wire-floored 
brooder batteries and provided unmedicated feed and water ad 
libitum.
Recombinant protein
The recombinant antigen 3264 was cloned from non- 
sporulated and sporulated oocysts of strain L.S. #24 E. 
tenella (Animal Parasitology Institute, Belstville, MD) as 
described previously (Danforth and Augustine, 1985) . A 
volume of 0.5 ml Freund's complete adjuvant (FCA) containing 
10 ug 3 2 64 was injected subcutaneously at the base of the 
neck into each bird. Serum was collected weekly from whole 
blood and stored frozen at -20 C until used.
IFA staining
Sporozoites were excysted by standard procedures, 
passed over a scrubbed nylon wool column to remove debris, 
centrifuged, and resuspended in phosphate-buffered saline 
(PBS). Merozoites were isolated from 5 day infected ceca, 
and purified on a DEAE-cellulose column (DE-52; Whatman, 
Clifton, NJ) using a pH 8.0 phosphate buffer. Purified 
sporozoites or merozoites at a concentration of 1  x 1 0 6/ml 
were fixed by air-drying to Toxoplasma titer slides. 7ir- 
dried parasites were reacted with serial dilutions of immune 
sera and incubated at room temperature in a humid chamber 
for 30 min. Slides were washed for 10 min in PBS, then
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reacted with rabbit anti-chicken IgG (Kirkegaard and Perry 
Laboratories, Gaithersburg, MD) diluted 1:30 in PBS and 
incubated for 3 0 min in humidity. A second 10 min wash in 
PBS was followed by reaction with fluorescein (FITC) 
conjugated goat anti-rabbit IgG (Kirkegaard and Perry 
Laboratories) diluted 1:30 for 30 min in humidity. Slides 
were washed a final time in PBS, mounted with glycerol and 
observed under UV light microscopy.
Results
Antibodies raised against the recombinant coccidial 
protein 3264 produced a distinct difference in labeling 
pattern between sporozoites and merozoites (Figs. 1-4) . 
Antibodies directed at sporozoites produced an intense 
anterior surface labeling (Fig. 1), while the same antibody 
preparations reacted with merozoites produced an intense 
posterior surface labeling on second generation merozoites 
only (Fig. 2) . First generation merozoites, about one-half 
the size of the second generation, appeared only slightly 
labeled, if at all. In addition, either a diffuse labeling 
pattern (Fig. 3) or a heavily stained nodule (Fig. 2,4) was 
also observed on the posterior surface of second generation 




This study investigated the antigen specificities of 
antisera raised in chickens against recombinant E. tenella 
antigen 3264. These results indicate that antigens which 
contain an epitope cross-reactive with recombinant antigen 
3264, are expressed on sporozoites and second generation 
merozoites. These findings also confirm previous work which 
described the ability of antisera raised against a similar 
recombinant antigen, 5401, to label E. tenella sporozoites 
(Danforth, 1985).
The labelling pattern found on first and second 
generation merozoites had not been described previously, and 
these results indicate that differences in antigen 
expression occur between sporozoites and merozoites. 
Although the apical region of the sporozoite was heavily 
labeled with antibody, these reactive antigens do not appear 
to be associated with the apical complex since first 
generation merozoites were not labeled and second generation 
merozoites were labeled only posteriorly. Therefore, these 
antigens appear to be associated with specific stages of 
parasite development and not ubiquitous expression on the 
parasite. Although labeling appears to be surface-oriented, 
the possibility that these antigens are expressed and 
therefore labeled internally cannot be ruled out.
The absence of fluorescence labelling of first 
generation merozoites by antisera produced following an
E. tenella oocyst infection was reported previously by
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Kouwenhoven and Kuil (197 6 ). In addition, similar 
fluorescence patterns were observed on both sporozoites and 
second generation merozoites suggesting that these stages 
shared common antigens not expressed on first generation 
merozoites. How these elicited antibodies function in the 
host response to parasitism is not yet understood. These 
antibodies' inability to label first generation merozoites 
may indicate that this parasite stage may be able to evade 
the host response. Johnson and coworkers (1979) concluded 
that the first generation merozoite was poorly immunogenic 
following studies with the attenuated WisF96 strain of E. 
tenella. which apparently develops through only one 
schizogonic cycle (McDougald and Jeffers, 1976). In
contrast, further work reported that WisF9 6  first generation 
merozoites were adequately immunogenic when the WisF96 
infection rate was adjusted to a rate quantitatively similar 
to that of the unattenuated parent strain of E. tenella 
(McDonald et al., 1986). In the present study, the epitope 
associated with 32 64 does not appear to be cross-reactive
with antigens expressed on the first generation merozoite 
and may explain why only partial protection was obtained in 
commercial chickens immunized with recombinant coccidial
antigen 5401 (Danforth, 1985).
Finally, the significance of the localized heavily 
labeled nodules on the surface of certain second generation 
merozoites requires further study. The possibility that
these nodules are assay artifacts must be considered,
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however, they are numerous and found only on the posterior 
surface of these merozoites. The nodules could be a result 
of surface-antigen capping prior to air fixation, or a 
result of the air-drying process itself. Similar antigen 
clusters were not found, however, on sporozoites. These 
immune complexes may indicate that cross-reactive antigens 
are sometimes expressed in localized surface clusters. Since 
these specific antigens apparently are not associated with 
the general merozoite surface, their function in development 
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Figures 1-4. Indirect fluorescent antibody (IFA) antigen 
labelling patterns, on or in air-dried sporozoites or 
merozoites, produced by antisera raised against recombinant 
coccidia protein 3264. All X 1600. 1. Anterior labelling of
sporozoites. 2. Posterior labelling of merozoites. 3. Dif­
fuse nodule labelling of posterior merozoite surface.




IN VIVO PROPAGATION OF EIMERIA TENELLA
Infection
1. Infect 5-6 wk old birds with 50,000 to 100,000 
sporulated oocysts. Harvest at 7-7.5 days.
Harvest
1. Remove cecal pouches from birds. Expel contents into
blender and wash out pouch with wash bottle.
2. Blend approx. 5 min.
3. Pour contents into 750 ml wide-mouth flask 
containing 5 g pepsin (1:15,000 activity), and bring volume 
to top with rinse from blender.
4. Adjust pH to 1.0-1. 8  with 10 N HC1.
5. Stir in 37 C waterbath for 2 h. (Never above 37 C.)
6 . Check under scope that fecal material has been 
reduced.
7. Adjust pH to 7.5-8.0 with 10 N NaOH.
8 . Pour contents into large jar and bring volume to 
top. Cover and let settle overnight.
9. Aspirate super; do not disturb sediment.
10. Swirl sediment and pour into 150 ml centrifuge tube. 
Rinse jar residue into a second tube.
11. Centrifuge at 1500 rpm for 10 min.
12. Aspirate of super. Combine tubes if necessary and 
centrifuge again.
13. Suspend pellet in 0.5% potassium dichromate. Aerate 
with air pump for 2-3 days. Check for degree of sporulation.
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Cleaning Oocvsts
1. Centrifuge dichromate suspension (1500 rpm/10 min).
2. Wash once with water.
3. Aspirate off water and add 15 ml clorox, resuspend 
oocysts;let stand in dark for 30 min. Shake occasionally.
4. Dilute with sterile water and centrifuge.
5. Wash twice with water.
6 . Resuspend in DMEM containing 2X antibiotic (PNS).
Excvstation of Sporozoites
1. Grind 7 ml of oocyst suspension in teflon tissue 
grinder to release sporocysts (§ 5-7 min).
2. Transfer contents to a 40 ml centrifuge tube, rinse 
grinder residue in to tube with Saline A. Fill tube to 40 ml 
line and vortex.
3. Centrifuge contents (2000 rpm/10 min) and discard 
super.
4. Add 20 ml excystation fluid, resuspend oocysts, and 
incubate at 37-41 C for 2-3 h (check ender scope). Agitate 
tube every 3 0 min.
5. Fill tube to 40 ml line with Saline A, vortex, and 
centrifuge. Discard super.
6 . Resuspend in tris buffer.
SALINE A




Make up in l L dH20 and filter sterilize.
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0.20.g KHCO3  
Dissolve into 1  L dH2 0.
3.03 g Trizma-8.0 (Sigma-T-4753)
Adjust pH to 8.0 if necessary.
Column Clean-up of Sporozoites
1. Pack 1 g scrubbed nylon fiber (Fenwal Laboratories, 
Deerfield, IL) into glass column or syringe. Pack tightly 
enough to permit a rate of flow of 2-3 drops/second.
2. Fill column with tris buffer and check rate of flow.
3. Fill column with tris buffer and allow it to drip 
through. Refill with tris and clamp off.
4. Wash sporozoite suspension IX in 40 ml tris buffer. 
Leave in 5 ml tris.
5. Allow column to empty. Place a centrifuge tube under 
the aseptic filling bell to collect filtrate. Pour 
sporozoite suspension onto the column and allow suspension 
to drain into the nylon fiber. Repeat with tris rinses of 
tube until a volume of 40 ml has been collected.
6 . Centrifuge filtrate from column. Discard super and 
resuspend sporozoite pellet in an appropriate medium.
— Resuspend in PBS if doing IFA's.
— Resuspend in Waymouth's 87/3 if infecting cells.
* Glass columns are made from 50 ml pipettes. The tip is cut 
off at about the 20 ml mark and discarded. A 3 1/2" length 
of latex tubing is fitted over the mouthpiece and connected 
to an aseptic filling bell.
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Merozoite Clean-up
1. Remove ceca, bloody core and split down the center. 
Place ceca in about 4 00 ml of DMEM per 7 bird samples. Stir 
for 2 0 min at moderate speed (10-15 min for acervulina) .
2. Centrifuge material at 300 rpm for 3 min.
3. Collect supernate and centrifuge at 1500 rpm for 10 
min. Discard supernate and resuspend sediment in 50 ml DMEM.
4. Centrifuge material at 700 rpm for 8  min. (The
supernate here is good for acervulina, so check.)
5. Resuspend sediment in 50 ml DMEM and centrifuge at 
1500 rpm for 1 min. Collect supernate, but check sediment 
for amount of merozoites lost. You may need to resuspend
this.
6 . Wash merozoites 2-3 times in phosphate buffer,
pH 8.0.
7. Pass supernate over a DE52 column (5-7 ml DE52 in a 
3 0 ml syringe plugged with scrub nylon fiber), equilibrated 
with phosphate buffer, pH 8.0. Collect approximately 3 5 ml.
8 . Centrifuge at 1500 rpm for 10 min and resuspend
merozoites in media of choice.
****Note all steps must be carried out under refrigeration.
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IFA PROCEDURE
1. Prepare suspension of sporozoites at 5 x l05 /ml.
2. Air dry 10,000 sporozoites/20 ul on toxoplasma titer 
slides (Belco Glass, ) . Store in -80 C. When using stored 
slides, let come to room temperature.
3. Expose air dried sporozoites to undiluted cell 
culture fluid or serial dilutions of serum for 3 0 min at 
37 C in humidity chamber.
4. Rinse and wash slides in F .A . PBS for 10 min at room
temp.
5. Blot dry and expose to anti-mouse/anti-chicken 
fluorescein conjugate (Kirkegaard and Perry) for 3 0 min at 
37 C in humidity chamber. Use 1/30 dilution of conjugate.
6 . Rinse and wash slides in F.A. PBS for 10 min at room
temp.
7. Mount with coverslips in 9 parts glycerol/l part PBS
8 . View under UV scope using 530 nm filter.
F.A. PBS
Solution A: 1.4 g NagHPC^/iqoml 
Solution B: 1.4 g NaH2 PO4/100 ml
Mix: 84.1 ml of A 
15.9 ml of B
8.5 g NaCl 




***Preparation of Parasite Antigen:
1~. Pellet sporozoites (want 2 x lo'/ml).
(4 x 107 merozoites)
2. Suspend in PBS.
3. Vortex 2 min with glass beads.
4. Draw off supernate into microfuge tubes; centr. 2 min.
5. Pool supernate and and run BIORAD total protein assay.
ELISA TEST
1. Carried out in plastic serocluster 96 well EIA
plates (Costar - 3590).
2. Dilute antigen in 50 mM carbonate-bicarbonate 
buffer pH 9.6 containing 0.1% (w/v) sodium azide (Ag concen. 
to 5-10 ug/well) . Allow 100 ul antigen to adsorb onto
plates at least 18 h at 4 C.
3. Wash Ag coated plates with PBS and block remaining 
adsorptive sites by incubation with 50 ul PBS containing 3% 
(w/v) BSA (Sigma S-7030) for 1 h at 41 C.
4. Add 50 ul log2  dilutions (1/50, 1/100, 1/200,etc.)
of serum/culture samples to be tested (in duplicate);
include positive/negative reference sera. Dilute sera in PBS 
with 0.05% Tween 20 (Sigma P-1379). Incubate 1 hr at 41 C.
5. Wash 3 times with PBS with 0.05% Tween 20.
6 . Add 50 ul 1/1000 dilution (in PBS with Tween) goat
anti-chicken/anti-mouse IgG (H+L) (Kirkegaard and Perry, 04- 
24-06) to each well. Incubate 1 hr at 41 C.
7. Wash 3 times with PBS-Tween 20.
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8 . Add 50 ul 1/1000 dilution (in PBS without Tween) 
peroxidase labelled rabbit anti-goat IgG (Kirkegaard and 
Perry)
9. Wash 3 times with PBS-Tween 20.
10. Add 150 ul substrate solution to each well. 
Incubate 30 min at 41 C.
9. Stop color reaction with 50 ul stop solution.
10. Read plates at 450 nm.
Preparation of Conjugate:
When received, dilute 1/10 with PBS and aliquot into 
lOOul volumes. Refreeze. Dilute 1/100 with PBS before use.
50 mM carbonate-bicarbonate buffer, pH 9.6 containing 0.1% 
sodium azide:
sodium carbonate, anhydrous (26.5 g/250 ml) 
sodium bicarbonate (21.0 g/250 ml) 
saline (8.12 g/1 NaCl)
1) Prepare stock solutions of 1 M carbonate and 1 M 
bicarbonate, (bicarb, does not keep)
2) Mix carbonate and bicarbonate 1:1 (v/v) and titrate 
pH to 9.6 with one of the stock solutions (carbonate 
increases pH, bicarb, decreases pH).
3) Dilute to the required molarity (1:2) with saline.
4) Add 0.1% sodium azide (1 g/1).
PBS containing 3% (w/v) BSA or 0.05% (v/v) Tween 20 
NaCl 8  . 0 g
KC1 0.2 g
Na 2 HP04  1.15 g (0.008 M)
KH,P04  0.2 g (potassium di-hydrogen phosphate)
Make up into 10X stock.
Add 3% BSA or 0.05% Tween 20 to final solution.
Substrate solution:
Buffer (10 mM citrate/phosphate buffer, pH 5) 
Sol'n A: 21.01 g/1 citric acid 
Sol'n B: 35.6 g/1 disodium phosphate 




Reconstitute l-l mg tablet TMB (Miles 98-051-1) 
in 10 ml 10 mM citrate/phosphate buffer. Swirl 
to dissolve. Store in dark up to 3 weeks.
TMB tablets stable up to 6  months at 5 C.
Substrate solution:
Add H 2 02  to final concen. of 0.01-0.1%. (add
66.7 ul to20 ml TMB stock).
Make up fresh each time.
Stop solution:






1.5 mm spacers 
combs
constant current power supply 
Preparation of Parasite Homegenate:
1. Pellet sporozoites/merozoites (want 2 x 10 /ml).
2. Suspend in sample buffer; need l ml for blank or 
7 5 ul/well, thus adjust vol. accordingly.
3. Draw off super into microfuge tube; centr. 2 min.
4. Draw off super into test tube and place in 100 C 
waterbath for 2  min.
5. Cool, then load onto gel.
6 . Use 10 ul BRL MW stds. in 65 ul sample buffer; 
follow steps 4 and 5.
Sample Buffer:
4.0 ml distilled water
1.6 ml 10% SDS
1.0 ml 0.5M Tris-HCl (pH 6 .8 )
800 ul glycerol
400 ul 2-beta-mercaptoethanol
200 ul 0.05% (w/v) bromophenol blue
8 . 0  ml
10% Separating Gel— 0.375M Tris. pH 8 . 8  
26.8 ml dH20
16.7 ml 1.5M Tris-HCl, pH 8 . 8  
670 ul 10% (w/v) SDS stock
22.2 ml Acrylamide/Bis (3 0 % stock)
2 00 ul 5% ammonium persulfate (fresh daily)
3 0 ul TEMED
6 6 . 6  ml total monomer (makes two 16 cm/1.5 mm gels)
Make solution minus APS and TEMED; add last and stir. 
Pipette into casting chamber quickly avoiding bubbles. 
Overlay with dH2 0.
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4.0% Stacking Gel— 0.125M Tris. pH 6 . 8
12.2 ml dH20 
5 ml 0.5M Tris-HCl, pH 6 . 8  
100 ul 10% (W/v) SDS
2.6 ml Acrylamide/Bis (3 0% stock)
1 0 0  ul 1 0 % ammonium persulfate (fresh daily)
20 ul TEMED
20 ml total monomer (enough for two 1.5 mm gels)
Prepare as for separating gel. Pour off water overlay.
Pipette into mold and insert comb.
Tank or Running Buffer— 0.025M Tris. p H 8.3; 0.192 alvcine
12.0 g Tris base
57.6 g glycine
40.0 ml 10% SDS
Bring up to 4 L; no need to check pH. Reuse the buffer in 
lower chamber 4-5X/s, but discard upper buffer after each 
run.
Load samples/standards onto stacking gel. Run through 
stacking gel at 25 mA (@ 30-60 min) . Run through separating
gel at 35 mA (@ 4-5 h) . Remove gels for transfer or
staining.
Stain
250 ml methanol (50%)
50 ml glacial acetic acid (10%)
62.5 ml coomassie blue (0.1%); from 1% stock (stir and 
filter)
Bring up to 500 ml.
Gently shake gels in stain 4-8 h.
Destain
1 0 0  ml glacial acetic acid (1 0 %)
500 ml methanol (50%)
Bring up to 1 L.
Gently shake in several washes.
STOCK SOLUTIONS
Acrvlamide/Bis f30%l
146 g acrylamide (29.2 g/lOOml)
4 g N'N'Bis—methylene—acrylamide (0.8 g/lOOml)
Make to 500 ml with dH2 0. Filter (Whatman #1) and store in 
dark, 4 C (30 days max.)
1.5M Tris-HCl. pH 8 . 8
54.45 g Tris base (18.15 g/lOOml)
@ 150 ml dH20
Adjust to pH 8 . 8  with 1 N HCl. Bring to 300 ml, store at 4 C
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0.5M Tris-HCl. pH 6 . 8
6.0 g Tris base 
@ 60 ml dH20
Adjust to pH 6 . 8  with 1 N HCl. Bring to 100 ml, store at 4 C 
10% SDS
Dissolve 10 g SDS in dH20 with gentle stirring and bring to 




1. Breakdown PAGE gels, remove stacking gel, and 
equilibrate 30 min in transfer buffer.
2. Wet filter paper, sponges, and nitrocellulose in 
transfer buffer.
3. Assemble blot sandwich according to western blot 
apparatus instructions. (I used a BioRad,. Richmond, CA, 
Trans Blot Cell).
4. Transfer either overnight at 30V or for 3 h at 75V. 
Chill transfer buffer prior to transfer.
B. Immunostaining:
1. After transfer, block nitrocellulose blot with 3% 
gelatin in TBS, pH 7.5, for either 2 h at 37 C or overnight 
at room temperature.
2. Rinse 2X with distilled water.
3. Primary antibody (chicken serum):
a. Dilute in Ab buffer with Tween 20; incubate 2-6 h 
at room temperature on a orbital mixer.
b. Wash 2X for 15 min each with PBS-Tween 20.
4. Secondary antibody (affinity purified anti-chicken):
a. Dilute 1/1000 in Ab buffer without Tween 20; 
react 2-3 h at room temperature on mixer.
b. Wash 2X for 15 min each with PBS-Tween 20.
5. Third antibody (affinity purified peroxidase labeled 
anti-goat):
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a. Dilute 1/1000 in Ab buffer without Tween 20; 
react 2-3 h at room temperature on mixer in dark (wrap in 
foil).
b. Wash 2X for 15 min each with PBS-Tween 20.
6 . Develop blots using peroxidase substrate development 
kit (Kirkegaard and Perry, Gaithersburg, MD) . Mix equal 
volumes of 4-chloro-naphthol and hydrogen peroxide, pour 
immediately onto nitrocellulose strips, and develop in dark 
for 10-15 min.
7. Wash with distilled water to stop development 
reaction. Dry and photograph as soon as possible.
Transfer Buffer, pH 8.3, 4 liters.
6.05 g Tris 
28.83 g Glycine 
8  00 ml Methanol 
4 ml 10% SDS 
3200 ml DH20
Tris-Buffered Saline (TBS), pH 7.5, 1 liter.
6.055 g Tris-HCL 
2 9.22 g NaCl 
Bring up to 1 L.
Antibody (Ab) Buffer, pH 7.5, 1 liter.
0.994 g Na2 HP0 4  
1.794 g NaH2 P04  
29.22 g NaCl
10.0 g Bovine Serum Albumen (BSA)
Bring up to l L.
Add 0.5 ml Tween 20 for buffer with Tween.
PBS-Tween 20, pH 7.5, 1  liter.
0.852 g Na2 HP0 4  
1.932 g NaH2 P04  
8.766 g NaCl 
0.5 ml Tween 20 
Bring up to l L.
